Dr.HeidiM.Mansour: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 1: Line 1:
==Contact Info==
'''Shalom Aleichem. Numen Lumen. Sursum. Lux libertas. Carpe Diem.
Dr. Heidi M. Mansour, Ph.D., R.Ph.
Assistant Professor of Pharmaceutics & Drug Delivery,
Faculty Associate in the UK Center of Membrane Sciences,
UK College of Pharmacy
Dept of Pharmaceutical Sciences-Drug Development
789 South Limestone Street
Office 331 Biological Pharmaceutical Complex
Lexington, Kentucky 40536-0596


Telephone: (859) 257-1571; Email: heidi.mansour@uky.edu
 
[[Image:HMM.jpg|150px]] [[Image: SmileTrain_CMYK_Primary_logowithtagline_fullcolor.jpg|350px]] [[Image: Wimbledon-tennis-club.JPG|300px]] <BR>
  [[Image: Wimbledon-tennis-lawn.jpg |250px]] [[Image: FHED---Wimbledon.jpg|200px]]  [[Image: CLF_photo.jpg|200px]]
<div style="padding: 10px; color: #ffffff; background-color: #000; width: 750px">
<center>
 
[[Mansour Lab | <font face="trebuchet ms" style="color:#ffffff"> '''Home''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Current Lab Members | <font face="trebuchet ms" style="color:#ffffff"> '''Current Lab Members''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Past Lab Members & Current Positions | <font face="trebuchet ms" style="color:#ffffff"> '''Past Lab Members & Current Positions''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Journal Publications | <font face="trebuchet ms" style="color:#ffffff"> '''Journal Publications''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Book Chapters | <font face="trebuchet ms" style="color:#ffffff"> '''Book Chapters''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Edited Book | <font face="trebuchet ms" style="color:#ffffff"> '''Edited Book''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Invited Talks | <font face="trebuchet ms" style="color:#ffffff"> '''Invited Talks''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Mansour Lab:Research Support | <font face="trebuchet ms" style="color:#ffffff"> '''Research Support''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</center>
</div><br>
 
 
=="The Leading Research University in the American Southwest" "Sursum"==
 
[[Image:UA.jpg |500px]]
 
Dr. Heidi Michaela Mansour, Ph.D.<BR>
The University of Arizona<BR>
College of Pharmacy, Dept. of Pharmacy Practice & Science<BR>
College of Medicine, Div. of Translational & Regenerative Medicine<BR>
The BIO5 Research Institute<BR>
1703 E. Mabel St., Office 434/Lab 435 Skaggs, Tucson, AZ 85721-0207. <BR>
 
Email: mansour@pharmacy.arizona.edu<BR>
 
[[Image:COP.png|500px]]


== Websites ==
== Websites ==
1. http://pharmacy.mc.uky.edu/faculty/HeidiMansour.php


2.http://www.linkedin.com/in/heidimansour
Clinton Foundation Ambassador [https://www.clintonfoundation.org/ways-give/become-clinton-foundation-ambassador]
 
Smile Train Premier Circle [https://www.smiletrain.org/donate/premier-circle]
 
Research & Education: [http://www.pharmacy.arizona.edu/directory/heidi-mansour-phd]


==Editorial Advisory Board Member (EAB)==
Graduate College Faculty Member:[http://graduate.pharmacy.arizona.edu/content/faculty-2]
1. Pharmaceutical Technology North America[http://pharmtech.findpharma.com/eab]


2. Journal of Nanomedicine & Nanotechnology [http://www.omicsonline.org/EditorialboardJNMNT.php]
Faculty Member, The BIO5 Research Institute: [http://www.bio5.org/]


3. Journal of Nanotechnology & Biotherapeutic Discovery [http://www.omicsonline.org/EditorialboardJNBD.php]
Affiliated Faculty Member, Institute of the Environment: [http://environment.arizona.edu/heidi-mansour]


4. Recent Patents on Nanomedicine [http://www.benthamscience.com/nanom/EBM.htm]
Associate Member [http://azcc.arizona.edu/profile/heidi-mansour], NCI Comprehensive Cancer Center: [http://azcc.arizona.edu/about]


5. Recent Patents on Drug Delivery & Formulation [http://www.bentham.org/ddf/EBM.htm]
Google Scholar Publications: [http://scholar.google.com/citations?hl=en&user=w2MFixQAAAAJ&sortby=pubdate&view_op=list_works&pagesize=100]
PubMed Publications: [http://www.ncbi.nlm.nih.gov/pubmed/?term=mansour+hm]
LinkedIn Profile: [http://www.linkedin.com/in/heidimansour]
Research Gate Profile: [https://www.researchgate.net/profile/Heidi_Mansour/info/?ev=prf_info]


6. Medicinal Chemistry: Current Research [http://www.omicsonline.org/editorialboardMCCR.php]
College of Pharmacy:  
http://www.pharmacy.arizona.edu/visitors/college-of-pharmacy-facts


7. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]
World Rankings in Pharmacy & Pharmacology (Global):
http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=+faculty=+stars=false+search=


==National Expert Committees==
World Rankings in Pharmacy & Pharmacology (USA):http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=257+faculty=+stars=false+search=
1. United States Pharmacopeia Delegate [http://www.usp.org/pdf/EN/members/2010-Delegates-and-Alternates.pdf]


2. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group-Aerosols
The University of Arizona:
http://www.arizona.edu/about/highlights-rankings


== Book Proposal Publisher Reviewer ==
The University of Arizona Medical Center:
1.Springer Publisher
http://uanews.org/story/university-of-arizona-medical-center-again-a-u-s-news-best-hospital


2.Marcel-Dekkar Publisher
==Professor Mansour Links==
1. University of Wisconsin-Madison, Dept. of Hebrew & Semitic Studies: [http://www.secfac.wisc.edu/senate/2002/0204/1606(mem_res).pdf]  [http://ancienthebrewpoetry.typepad.com/ancient_hebrew_poetry/2008/02/how-well-do-you.html]<BR>
Rabbi Eli Mansour [http://www.dailyhok.com/AboutUs.aspx?Type=AboutRabbi]
Mansoura Jewish Business [http://www.mansoura.com/about_us.html]


3.Elsevier Publisher
2. Tel Aviv University: [http://www.cs.tau.ac.il/~mansour/bio.htm] [http://www.tau.ac.il/~mansour/CV_Yishay_Mansour.htm]


4.Wiley-Interscience Publisher
3. Harvard Medical School: [http://www.massgeneral.org/heartcenter/doctors/doctor.aspx?ID=17326]


5.Pharmaceutical Press-The Royal Pharmaceutical Society of Great Britain
4. Stanford University School of Medicine, Molecular Pharmacology: [http://med.stanford.edu/news/all-news/2011/11/stanford-pharmacology-leader-tag-mansour-dies-at-86.html] [http://www.paloaltoonline.com/obituaries/memorials/tag-eldin-mansour?o=1536]


== Honors & Awards ==
5. Emory University School of Medicine: [http://www.surgery.emory.edu/about-us/faculty_directory/faculty_profile_kamal_mansour.html]
 
6. University of Texas Southwestern Medical Center: [http://profiles.utsouthwestern.edu/profile/95877/john-mansour.html]
 
7. Case Western Reserve  University School of Engineering: [http://engineering.case.edu/emae/Faculty/Joseph_Mansour]
 
8. University of Colorado-Denver:[http://www.ucdenver.edu/academics/colleges/CLAS/Departments/economics/Faculty/tenure-track/Pages/HaniMansour.aspx][http://econ.ucdenver.edu/mansour/]
 
9.University of Utah, Dept. of Molecular Biology & Human Genetics: [http://www.bioscience.utah.edu/faculty/molecular-biology-faculty/mansour/mansour.php] [http://www.genetics.utah.edu/?page_id=707]
 
10.The University of Texas: [https://med.uth.edu/ortho/faculty/alfred-mansour/]
 
11. United States Military Academy West Point: [http://www.usma.edu/dfl/_layouts/wpFacultyBios/DisplayBio.aspx?ID=18c5e94c-a88c-4dcb-b4c2-9326bed348e2&List=ff1aa393-5361-4ea7-8f4a-716c2c8db018]
 
==Education==
 
Postdoctorate, University of North Carolina-Chapel Hill[http://unc.edu/], School of Pharmacy[https://pharmacy.unc.edu/news/schoolnews/mansour-earns-three-postdoctoral-awards], 1/2006-6/2008.<BR>
[[Image:UNC-chapel-hill.jpg.png|200px]] [[Image:Unc_seal.jpg|80px]]
 
Postdoctorate, University of Wisconsin-Madison[http://www.wisc.edu/], School of Pharmacy[http://www.pharmacy.wisc.edu/newsletter/may2013][http://www.pharmacy.wisc.edu/newsletter/july2013], 2004.<BR>
[[Image:UW.jpg|100px]] [[Image:Forward badger.jpg|100px]]
 
Ph.D. Major-Pharmaceutical Sciences (Pharmaceutics & Drug Delivery), University of Wisconsin-Madison, School of Pharmacy, 12/2003.<BR>
Ph.D. Minor-Advanced Physical & Biophysical Interfacial Chemistry, University of Wisconsin-Madison, Department of Chemistry, 12/1999.<BR>
[[Image:IMG_0725.JPG|100px]] [[Image:Siftwinnow.jpg|100px]]
 
B.S.-Pharmacy (Distinction & Honors), University of Wisconsin-Madison, 5/1996. <BR>
[[Image:UW_SOP.png|100px]] [[Image:Numen_Lumen.png|80px]]
 
==Health Professional Licensure==
 
Registered Pharmacist 8/1996-Present. <BR>
[[Image:Rx_snake.png|70px]]  [[Image:Bucky_Badger_RPh.jpg|80px]]
 
==Research Program==
Research in the Mansour lab focuses on the fundamental and applied aspects of surface and interfacial chemistry, nanotechnology, and particle engineering technologies in the design and optimization of advanced drug delivery systems.  Multifunctional polymeric phospholipid (lipopolymeric) self-assemblies are optimized for targeted drug delivery, nanomedicine, and multifunctional microparticles and nanoparticles in the solid-state as dry powder inhalation aerosols in the targeted treatment and prevention of several pulmonary diseases. These microparticulate/nanoparticulate dry powders which are targeted directly to the lung as dry powder inhalers are biocompatible, biodegradable, mucopenetrating, and provide sustained drug release. We utilize various types of inhaler devices for both ''in vitro'' and ''in vivo'' rodent animal models. A systematic Quality-by-Design (QbD) approach in the solid-state is used and includes comprehensive physicochemical characterization, design of experiments (DOEs), performance modeling, and prediction.  Pulmonary diseases with unmet medical needs that we investigate ''in vitro'' and ''in vivo'' include lung transplantation, lung cancer, infectious diseases, lung inflammatory fibrotic diseases, and autoimmune diseases. Our research program includes translational medicine, as exemplified by several successful collaborations with physician-scientists.
 
==Editorial Advisory Board Member (EAB)& Scientific Advisor==
1. Pharmaceutical Technology [http://www.pharmtech.com/heidi-m-mansour-phd-rph-university-arizona-tucson-tucson-az]
 
2. Recent Patents on Nanomedicine [http://benthamscience.com/journal/editorial-board.php?journalID=rpnanom#top]
 
3. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]
 
4. Journal of Pharmaceutical Sciences-Scientific Advisor to the Editors [http://mc.manuscriptcentral.com/societyimages/jpharmsci/List%20of%20Scientific%20Advisor%20Keyword%20List.xlsx] [http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-6017/homepage/EditorialBoard.html]
 
5. Austin Journal of Pulmonary and Respiratory Medicine [http://austinpublishinggroup.com/pulmonary-respiratory-medicine/editorialboard.php]
 
==National Expert Committees & Study Sections==
1. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group<BR>
[[Image:NICHD.jpg|300px]]
 
2. NIH/NIAID<BR>
[[Image:NIAID.jpg‎|450px]]
 
3. NIH/NCI<BR>
[[Image:NCI.png‎|450px]]
 
4.NIH/NIBIB<BR>
[[Image:NIBIB.png|400px]]
 
5. American Association for the Advancement of Science (AAAS)<BR>
[[Image:AAAS.jpg|200px]]
 
6. National Science Foundation<BR>
[[Image:Nsf_logo.png |500px]]
 
7. NIH, Center for Scientific Review (CSR), Oncology 2 - Translational Clinical  ZRG1
 
8. NIH, CSR, Pediatric Formulations & Drug Delivery Systems Study Section ZRG1 ETTN-B 50 R
 
9. NIH, CSR, NIAID Study Section ZAI1 RRS-M (C3)
 
10. NIH, CSR, NIAID Study Section ZAI1 BP-A (C1)
 
11. NIH, CSR, Bioengineering Sciences & Technologies Integrated Review Group, NANO Study Section
 
12.NIH, CSR, NCI Innovative Cancer Nanotechnology Study Section  2015/10 ZCA1 TCRB-9 (O1) R
 
13. The Rutgers Brain Health Institute,Rutgers University-Newark and New Jersey Institute of Technology, Pilot Grant Program [https://brainhealthinstitute.rutgers.edu/funding-opportunities/intramural-funding/]
 
14. AZ Area Health Education Centers (AHEC) Faculty Development Research Grants Program
 
15.NIH, CSR, NCI Study Section
 
16.NSF Nano-Bio Phenomena and Processes in the Environment Program Study Panel
 
==International Expert Peer Reviewer==
1. Indo-US Science & Technology
 
2. Austrian Science Fund
 
3. German-Israeli Foundation (GIF) for Scientific Research and Development
 
4. Deutscher Akademischer Austauschdienst Dienst (DAAD)German International Academic Exchange Service
 
5. Catalent Applied Drug Delivery Institute
 
6. Cochrane Airways Group, NHS National Institute for Health Research, Great Britain [http://airways.cochrane.org/external-peer-reviewers]
 
7. Engineering Physical Sciences Research Council (EPSRC), Great Britain
 
8. Engineering and Physical Sciences Research Council (EPSRC), Research Councils, Great Britain
 
9. PRESTIGE Marie Curie Post-doc Fellowships Programme,The European Commission & Campus France, Paris, France
 
10.Biomedical Innovation Program, French National Research Agency, Paris, France
 
== Honors/Awards/Fellowships ==
*2015, Fellow, The Royal Society of Medicine (London, GBR)
*2015, Elected Co-Chair, Drug Delivery: New Devices & Emerging Therapies Group,International Society for Aerosols in Medicine (ISAM)
* 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
* 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
* 2010, Scholarship of Teaching & Learning Certificate (STLC) Award, UK College of Pharmacy, University of Kentucky
* 2007, NIH Regional Training Award Scholar, National Institutes of Health (NIH)/UNC-Chapel Hill
* 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
* 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
* 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
* 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
Line 66: Line 207:
* 1991, Elected Member, Phi Eta Sigma National Honor Society
* 1991, Elected Member, Phi Eta Sigma National Honor Society
* 1991, Elected Member, Phi Kappa Phi National Honor Society
* 1991, Elected Member, Phi Kappa Phi National Honor Society
* 1991, Elected Member, Golden Key International Honor Society  
* 1991, Elected Member, Golden Key International Honor Society
 
==Research Support==
 
[[Image:FDA.jpg‎ |200px]]        [[Image:NIH.jpg |120px]]    [[Image:Nsf_logo.png |500px]] <BR>
 
[[Image:NIAID.jpg‎|500px]]  <BR>
 
[[Image:OSUCOMLogo.png|450px]] <BR>
 
[[Image:NCH.jpg|300px]] <BR>
 
[[Image:JHU.png|250px]] <BR>
 
[[Image:NCI.png‎|500px]] <BR>
 
[[Image:Sungkyunkwan.png |150px]]            [[Image:UA_BIO5.png |350px]]
 
[[Image:Cureveda.jpg|250px]] [[Image:GSK.png |200px]] [[Image:Buchi.jpg |150px]] [[Image:Oakwood.png |200px]] [[Image:Pfizer.jpg |150px]] [[Image:BI.jpg |200px]] [[Image:Insys.jpg‎ |200px]]


==Invited Speaker (2005-Present)==
==Invited Speaker (2005-Present)==
1.Yale University, Department of Biomedical Engineering, New Haven, CT.


2.Harvard University, Division of Engineering and Applied Sciences, Cambridge, MA.  
'''''National and International Invited Speaker Presentations'''''
 
1.Yale University, Department of Biomedical Engineering, New Haven, CT. 2005.
 
2.Harvard University, Division of Engineering and Applied Sciences, Cambridge, MA. 2005.
 
3.UNC-Chapel Hill, Chapel Hill, NC. 2005.
 
4.10th Annual Liposome Research Days & 1st UNC Drug Conference, Chapel Hill, NC. 2006.
 
5.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Phoenix, AZ.
Symposium on Phospholipids:''"Lipids in Nanotechnology II"''. Invited Speaker. Presentation Title:  ''“Designed Phospholipid Self-Assemblies in Drug Delivery and Nanomedicine”''. 2010. [http://www.aocs.org/archives/am2010/index.cfm?page=101st-AOCS-Annual-Meeting-Program-Tech-Prog&interest=Phospholipid]
6.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Cincinnati, OH. Symposium on ''“Phospholipids in Pharma and Cosmetics Applications”''. Invited Speaker. Presentation Title: ''"Phospholipid Nanopharmaceuticals in Advanced Drug Delivery".'' 2011. [http://www.aocs.org/archives/am2011/abstracts.cfm?interest=Phospholipid]
 
7.International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Solid-State Transformation During Formulations and Processing”''.  Invited Speaker. Presentation Title: ''"Water Vapor-Solid Interactions and Effects on Solid-State Phase Transitions in Engineered Microparticulate/Nanoparticulate Pharmaceutical Powders".'' 2011.
 
8. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Imaging of Drugs and Dosage Forms to Better Understand Dissolution”''. Invited Speaker. Presentation Title: ''"Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders".'' 2011.
 
9. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on ''“Nanomedicine: Colloids & Surface Science”''. Denver, CO.
 
Symposium Session Chair Presider [http://acselb-529643017.us-west-2.elb.amazonaws.com/chem/242nm/program/divisionindex.php?act=presentations&val=Nanomedicine:+Colloid+and+Surface+Science&ses=Nanomedicine:+Colloid+and+Surface+Science&prog=62147]
 
Invited Symposium SpeakerPresentation Title: ''"Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”.'' 2011.[http://acselb-529643017.us-west-2.elb.amazonaws.com/chem/242nm/program/divisionindex.php?act=presentations&val=Nanomedicine:+Colloid+and+Surface+Science&ses=Nanomedicine:+Colloid+and+Surface+Science&prog=62147]
 
10. 4th Annual AAPS Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: ''"Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery.''" 2011.
 
11. Pfizer, Inc., Worldwide Research & Development, Global Headquarters, Groton, CT. Invited Speaker. Presentation Title: ''"Engineering Particles by Advanced Spray Drying for Drug Delivery.''" 2011.
 
12. Center for Pulmonary Research, Children's Hospital Research Institute, The Ohio State University, Columbus, OH. Invited Speaker in the Translational Pulmonary Research Seminar Series. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''" 2012.
 
13. International Conference & Exhibition on Nanotechnology & Nanomedicine. Omaha, NE. Invited Speaker. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''" 2012.


3.UNC-Chapel Hill, Chapel Hill, NC.  
14.Transcept Pharmaceuticals. Invited Webinar Speaker. Presentation Title: ''"Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery''". 2012.


4.10th Annual Liposome Research Days & 1st UNC Drug Conference, Chapel Hill, NC.  
15. Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker. Presentation Title: ''"Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery.''" 2012. [http://www.niroinc.com/pdfs/news/spray_drying_course_flyer_2012.pdf]


5.PEPSIG, UK COP & UK Engineering, Lexington, KY.
16. Lovelace Respiratory Research Institute (LRRI). Albuquerque, NM. Invited Speaker in the LRRI and CNTC Seminar Series. Presentation Title:''"Advances in Targeted Lung Nanomedicine as Aerosolized Multifunctional Microparticles and Nanoparticles for Pulmonary Disease Treatment and Prevention.''"  2012. [http://cntc.unm.edu/news.html]


6.International Society of Pharmaceutical Engineers (ISPE), UK College of Engineering, Lexington, KY. Invited Speaker.  
17. Controlled Release Society (CRS) 39th Annual Meeting & Exhibition. Quebec City, Quebec, Canada. Invited Speaker. CRS Workshop: ''"Mucosal Drug and Gene Delivery: Barriers and Opportunities.''"  Presentation Title: ''"Pulmonary Drug Delivery''".  2012.[http://www.controlledreleasesociety.org/meetings/Archives/2012AnnualMeeting/program/Pages/YoungScientistWorkshops.aspx]


7.UK College of Medicine-Pulmonary Medicine Division/Pediatric Research Group Seminar.  
18. 1st International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis. University of Delaware, College of Health Sciences, Newark, DE.  Organizing Committee Member [http://www.udel.edu/nanomedicine/presenters.html].  Nano Drug Delivery Session Chair Presider [http://www.udel.edu/nanomedicine/schedule.html]. Invited Symposium Speaker in the Nanomedicine Session. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Multifunctional Microparticles & Nanoparticles for Targeted Pulmonary Delivery."'' 2012. [http://www.udel.edu/nanomedicine/schedule.html]


8.UK College of Engineering-NSF REU Faculty Panel Speaker, Lexington, KY.  
19. Wayne State University Applebaum College of Pharmacy, Department of Pharmaceutical Sciences Seminar Series. Detroit, MI. Invited Speaker. 2012.[http://events.wayne.edu/research-events/2012/10/03/pharmaceutical-sciences-seminar-advances-in-targeted-lung-nanomedicine-as-a-41923/]


9.UK Lung Biology Group & UK Pulmonary Medicine Research Conference Seminar,College of Medicine-Pulmonary Medicine Division, Lexington, KY.  
20. North American Cystic Fibrosis Conference (NACFC), Orlando, FL.  Invited Symposium Speaker. NACFC Aerosol Symposium: ''"Aerosol Treatments in CF: Clearing the Fog."'' Presentation Title: ''"Aerosol Formulation Issues."'' 2012.[http://www.softconference.com/nacfc/sessionDetail.asp?SID=293839]
 
10.UK Center of Membrane Sciences Faculty Associates Research Symposium, Lexington, KY.
21. 19th World Congress of the International Society of Aerosols in Medicine (ISAM), Chapel Hill, NC. Invited Speaker. ISAM Workshop: ''"Nanomedicine & Nanotoxicology: Inhaling nanoparticles by accident and on purpose-challenges and opportunities for toxicology and therapeutics.''" Presentation Title: ''"Nanotechnology in Dry Powder Inhalation Aerosol Formulations."'' 2013.[http://www.med.unc.edu/isam2013/files/isam2013-inhaling-nanoparticles-by-accident-and-on-purpose-challenges-and-opportunities-for-toxicology-and-therapeutics-1]
 
22. AAPS/USP/FDA/IPAC Workshop on Inhaled Drug Products, United States Pharmacopeia (USP), Rockville, MD. Invited Speaker. ''"Inhaled Drug Products: Current Practices and the Future of In Vitro Testing Technologies and Regulation.''" Presentation Title: ''"Solid-State Characterization and Nanotechnology in Inhalation Aerosol Formulation Development."'' 2013. [http://www2.aaps.org/uploadedFiles/Functional/AAPS_Focus_Group_Discussion_Board/Inhalation_and_Nasal_Technology_Focus_Group/INTFG_Newsletter_Summer2013.pdf]
 
23. Association of Inhalation Toxicologists (AIT) Annual Conference, Hannover, Germany. Invited Speaker. Session: ''"Nanomaterials.''" Presentation Title: ''"Nanomaterials as an Aerosol Formulation Carrier in Inhalation Aerosol Nanomedicine.''" 2013. [http://www.aitox.org/events.html]
 
24. Eastern Analytical Symposium & Exhibition (EAS), Somerset, NJ. Invited Speaker. Coblentz EAS Session: ''"Spectroscopic Applications in Biologics.''" Presentation Title:''"Characterization and Spectroscopic Applications in Pulmonary Delivery and Advanced Dry Powder Inhalers."'' 2013. [http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CDAQFjAA&url=http%3A%2F%2Feasinc.org%2Fwordpress%2Fwp-content%2Fuploads%2F2013%2F04%2FInvited-Sessions-Retort-13-web.pdf&ei=VoyCUeKwDNG90QGh14GoBA&usg=AFQjCNHd1WIxlTFWwyTfKeL2VfTuSfK5FA&sig2=A8ZIGQZUAAcng7OImT7dqA&bvm=bv.45921128,d.dmQ] [http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&ved=0CDYQFjAB&url=http%3A%2F%2Feasinc.org%2Fwordpress%2Fwp-content%2Fuploads%2F2013%2F04%2FEAS-April-Retort-2013-final1.pdf&ei=VoyCUeKwDNG90QGh14GoBA&usg=AFQjCNGelg8XbLU_hEjKQSfljVJUd5pUkw&sig2=UNYlvhfPSxucRKODNoIRzg&bvm=bv.45921128,d.dmQ]
 
25.Buchi Hands-On Spray Drying Course, Newark, DE. Invited Speaker Presentation: ''"Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying.''" 2014. [http://www.buchi.com/en/node/1689]
 
26.American Chemical Society (ACS) 249th Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry Symposium, Denver, CO. Invited Symposium Presentation: ''"Advances in Targeted Multifunctional Inhalation Aerosols with Nanotechnology and Solid-State Particle Engineering Design."'' 2015.
 
27. American Thoracic Society (ATS) International Conference joint with ISAM, Denver, CO. ATS/ISAM Presentation: ''"Multifunctional Nanotechnology in Lung Surfactant-Mimic Inhalation Aerosols as High-Performing Dry Powder Inhalers for Targeted Pulmonary Medicine."'' 2015.
 
28. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: ''"Inhalation Pharmaceuticals: Device Design and Formulations."'' 2015. [http://www.inhalationmag.com/content/SiteContent.aspx?ID=608]
 
29. Gordon Research Conference on Lung Biology, Injury, and Repair: Translating Lung Biology to Respiratory Medicine. 2015. Invited Presentation: ''"Translating Lung Surfactant Biophysics, Nanotechnology, and Nrf2/KEAP-1Genetic Pathway to Advanced Dry Powder Inhalation Aerosol Medicine.''"
 
30. Aerogen Webinar ''"Mechanisms & Pharmacology of Inhaled Drug Delivery"'' joint with Harvard University School of Public Health (Dr. Joseph Brain), National Jewish/Univ. of Colorado (Dr. Ronina Covar), and Aerogen (Dr. Richard Rose and Dr. Jim Fink). Invited Presentation: ''"Pharmacology of Inhaled Therapeutics."'' 2016. [http://www.tri-anim.com/data/default/productattachments/THS-Aerogen-Webinar.pdf][http://edu-review.org/ce.aspx?a=viewPost&PostID=29739]
 
31. American Chemical Society (ACS) 90th Colloid & Surface Science Symposium at Harvard Univ. Cambridge, MA. Session: ''"Nanomaterials for Biomedicine."''Invited Symposium Speaker Presentation: ''"Advances in Biomimetic Nanomaterials for Multifunctional Inhalation Aerosols in Pulmonary Biomedicine."''2016.
32. Controlled Release Society (CRS) Annual Meeting, Seattle, WA. Co-Chair, Scientific Symposium: ''"New Processes, New Materials, and New Products."'' 2016.
 
33. International Society of Aerosols in Medicine (ISAM) Aerosol School, Firestone Institute for Respiratory Health & McMaster University, Hamilton,Ontario,Canada.Faculty. 2016.[http://aerosolschool.com/faculty.html]
 
==Invited Webinar Presentations==
1. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: ''"Inhalation Pharmaceuticals: Device Design and Formulations."'' July 14, 2015. 300 attendees. [http://www.inhalationmag.com/content/SiteContent.aspx?ID=608]
 
2. Aerogen Webinar ''"Mechanisms & Pharmacology of Inhaled Drug Delivery"'' joint with Harvard University School of Public Health (Dr. Joseph Brain), National Jewish/Univ. of Colorado (Dr. Ronina Covar), and Aerogen (Dr. Richard Rose and Dr. Jim Fink). Invited Presentation: ''"Pharmacology of Inhaled Therapeutics."'' January 19, 2016. 960 attendees.[http://www.tri-anim.com/data/default/productattachments/THS-Aerogen-Webinar.pdf][http://edu-review.org/ce.aspx?a=viewPost&PostID=29739]
 
==International/National Spotlight Research Media Coverage==
 
'''''International'''''
 
1.''Insight & Interview: Drug Delivery & Formulation-Controlled Release.'' [[World Pharmaceutical Frontiers]] (2011) 2 (September): 61-64.[http://www.worldpharmaceuticals.net/features/featurecontrolled-release-drugs-mansour-deluca/]
 
2.''Insight & Interview: Meeting Manufacturing Challenges Tied to Extended-Release Injectables.'' [[Pharmaceutical Technology]] (2012) 36 (5): 40-47.[http://www.pharmtech.com/meeting-manufacturing-challenges-tied-extended-release-injectables]
 
3.''Named in “Top Reviewers in 2012.''  [[Nanomedicine: Nanotechnology, Biology, and Medicine]] (2012) [Impact Factor: 6.155] [http://www.nanomedjournal.com/content/reviewers2012]
 
4.''Named in “Top Reviewers in 2013.''  [[Nanomedicine: Nanotechnology, Biology, and Medicine]] (2013) [Impact Factor: 6.155] [http://www.nanomedjournal.com/content/reviewers2013]
 
5.''High-Precision Pulmonary Medicine.'' [[International Innovation]] (2015) 185 (Health & Nanomedicine):99-101. [http://www.internationalinnovation.com/?smd_process_download=1&download_id=26524][http://www.internationalinnovation.com/high-precision-pulmonary-medicine/]
 
6.''Aerosol Medicine.'' [[Pan European Networks: Science & Technology]] (2015) 16:1-2. [http://www.paneuropeannetworks.com/science-publications/science-technology-publication/]
 
7.''Pulmonary Disease Research.'' [[Adjacent Government]] (2015): 80-81.[http://www.adjacentgovernment.co.uk/lg-edition-007/profile-pulmonary-disease-research/20370/]
 
8.''Acknowledgement to Reviewers of Pharmaceutics in 2014.''  [[Pharmaceutics]] (2015) 7: 1-2.
 
9.''Named in “Top Reviewers in 2014”.'' [[Nanomedicine: Nanotechnology, Biology, and Medicine]] (2015) [Impact Factor: 6.155][http://www.nanomedjournal.com/content/reviewers2014]
 
 
'''''National'''''
 
1.''In the Spotlight: May 21, 2014''[[College News: UA College of Pharmacy]] (2014)[http://www.pharmacy.arizona.edu/stories/bulletin/spotlight-may-21-2014]
 
2.''Nov. 19, 2014''[[Bulletin: UA College of Pharmacy]](2014)[http://www.pharmacy.arizona.edu/bulletin/218]
 
3.''Grants: Nov. 19, 2014'' [[College News: UA College of Pharmacy]] (2014)[http://www.pharmacy.arizona.edu/stories/bulletin/grants-nov-19-2014]


11.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Phoenix, AZ.
4. ''Grants: Jan. 26, 2015 | College of Pharmacy - University of Arizona'' [[UA College of Pharmacy]][http://www.pharmacy.arizona.edu/stories/grants-jan-26-2015]
Symposium on Phospholipids:''"Lipids in Nanotechnology II"''. Invited Speaker. Presentation Title:  ''“Designed Phospholipid Self-Assemblies in Drug Delivery and Nanomedicine”''.  
12.UK Dept of Biomedical Engineering Seminar Series, Lexington,KY.  
Invited Speaker. Presentation Title:  ''"Advances in Sustained-Release Injectable Depot Drug Delivery and Controlled Release Pulmonary Inhalation Aerosol Drug Delivery"''


13.International Society of Pharmaceutical Engineers(ISPE), Lexington, KY.
5.''March 2015 - AHSC New Awards'' (2015) [https://www.google.com/url?q=http://opa.ahsc.arizona.edu/sites/opa.ahsc.arizona.edu/files/uploads/ahsc_new_awards_march_2015.pdf%3Futm_source%3DArizona%2BHealth%2BSciences%2BCenter%2BNewsletter%26utm_campaign%3D7b8ec0a76d-AHSC_Newsletter_April_20154_15_2015%26utm_medium%3Demail%26utm_term%3D0_4b16f9a294-7b8ec0a76d-319061049&sa=U&ved=0ahUKEwj7z4bQ_JDKAhXHqx4KHalwAk04FBAWCB0wCQ&client=internal-uds-cse&usg=AFQjCNF3Uskz2ozQCUV9xrDJuHhGNLFFkw]
Invited Speaker. Presentation Title: ''"Targeted Pulmonary Dry Powder Inhalation Aerosols: Pulmonary Infection Drug Delivery & Non-Invasive Needle-Free Pulmonary Vaccines".''


14.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Cincinnati, OH. Symposium on ''“Phospholipids in Pharma and Cosmetics Applications”''. Invited Speaker. Presentation Title: ''"Phospholipid Nanopharmaceuticals in Advanced Drug Delivery".''
6. ''In the Pharmacy Spotlight'' [[AHSC]] (2015)[http://memo.ahsc.arizona.edu/index.cfm/memos/view/24173/dbb4ef818d2e794b]


15.International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Solid-State Transformation During Formulations and Processing”''. Invited Speaker. Presentation Title: ''"Water Vapor-Solid Interactions and Effects on Solid-State Phase Transitions in Engineered Microparticulate/Nanoparticulate Pharmaceutical Powders".''
7. ''College of Pharmacy Faculty Earn Leadership Roles, Professional Honors'' [[Awards and Accolades | UA@Work]] (2015)[https://uaatwork.arizona.edu/lqp/awards-and-accolades-52]


16. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on ''“Imaging of Drugs and Dosage Forms to Better Understand Dissolution”''. Invited Speaker. Presentation Title: ''"Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders".''
8. ''Three Earn Recognition at College of Pharmacy'' [[UA College of Medicine: AHSC News Includes Many Activities for Fall DOM Calendars]](2015)[http://deptmedicine.arizona.edu/news/ahsc-news-includes-many-activities-fall-dom-calendars]


17. "Hanging with Zwisch" Research Colloquium, UK College of Medicine-Dept of Pulmonary & Surgery. Lexington, KY. Invited Speaker.
9.''College of Pharmacy faculty earn leadership roles, professional honors''[[COP in the News: Oct. 27, 2015]](2015)[http://www.pharmacy.arizona.edu/stories/cop-news-bulletin/cop-news-oct-27-2015]
Presentation Title : ''"Advances in Targeted Lung Delivery as Inhaled Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention”.''


18. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on ''“Nanomedicine: Colloids & Surface Science”''. Denver, CO. Symposium Session Presider & Invited Symposium Speaker. Presentation Title: ''"Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”.''
10.''In the Pharmacy Spotlight'' [[COP in the News: Sept. 21, 2015]] (2015) [http://www.pharmacy.arizona.edu/stories/cop-news-bulletin/cop-news-sept-21-2015]


19. 4th Annual Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: ''"Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery.''"
11.''In the Pharmacy Spotlight''[[AHSC Announcements - Sep 18, 2015]](2015)[http://memo.ahsc.arizona.edu/index.cfm/memos/view/24273/e5da6d7ee7a0ac29]


20. Pfizer, Inc., Worldwide Research & Development, Global Headquarters, Groton, CT. Invited Speaker. Presentation Title: ''"Engineering Particles by Advanced Spray Drying for Drug Delivery.''"
12.''In the Spotlight: Aug. 31, 2015'' [[College News: UA College of Pharmacy]](2015)[http://www.pharmacy.arizona.edu/stories/spotlight-aug-31-2015]


21. International Conference & Exhibition on Nanotechnology & Nanomedicine. Omaha, NE. Invited Speaker. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''"
13. "KEYS Research Internship" (2015)[https://www.google.com/url?q=https://keys.pharmacy.arizona.edu/sites/keys.pharmacy.arizona.edu/files/Research%2520Showcase%2520Booklet%2520FINAL.pdf&sa=U&ved=0ahUKEwj7z4bQ_JDKAhXHqx4KHalwAk04FBAWCA0wAw&client=internal-uds-cse&usg=AFQjCNGmg6lv8GwlsUuT4nDSnEzMJc6qrg]


22. International Society of Pharmaceutical Engineers(ISPE). Invited Speaker. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''"
14. "UROC Research Consortium" [[UROC Prep]] (2015) [https://www.google.com/url?q=https://grad.arizona.edu/uroc/sites/default/files/uagc_page/urocprep_abstracts.pdf&sa=U&ved=0ahUKEwjz4dOSg5HKAhVIWh4KHQMfBjs4HhAWCAQwAA&client=internal-uds-cse&usg=AFQjCNEptELkbxpLqdPK1bf1k5hnRFpQlg]


23.Transcept Pharmaceuticals. Invited Speaker. Presentation Title: ''"Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery''".
15."Winter Series Lung Conference: Lung Research" [[UA College of Medicine & Arizona Respiratory Center]] (2015)[http://deptmedicine.arizona.edu/pulmonary/researcheducation]


24. Buchi Annual Spray Drying Short-Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker. Presentation Title: ''"Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery.''"
16. Univ of Arizona College of Pharmacy Homepage Rotating Research Group Profile (2015) [http://www.pharmacy.arizona.edu/]


25. 1st International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis. Newark, DE.  Session Chair Presider & Invited Symposium Speaker. Presentation Title: ''"Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention.''"
17. ''COP faculty member develops treatments for lung diseases'' (2015)[http://www.pharmacy.arizona.edu/features/faculty-staff/cop-faculty-member-develops-treatments-lung-diseases]


26. 2nd International Symposium on Surface Science: Adhesion Aspects in the Pharmaceutical Sciences. Mid-Hudson Valley, NY. Session Chair Presider & Invited Speaker.
18.UA College of Medicine, Dept of Medicine, faculty research news plus video  [http://deptmedicine.arizona.edu/news/ua-college-pharmacy-faculty-member-dr-heidi-mansour-develops-inhalers-treat-lung-diseases]


27. North American Cystic Fibrosis Conference (NACFC), Orlando, FL. Aerosol Symposium: "Aerosol Treatments in CF: Clearing the Fog." Invited Symposium Speaker. Presentation Title: "Aerosol Formulation Issues in Targeted Pulmonary Inhalation Aerosol Delivery"
19.UA Health Sciences Office of Public Affairs faculty research news plus video [http://opa.ahsc.arizona.edu/newsroom/news/2016/ua-college-pharmacy-faculty-member-dr-heidi-mansour-develops-inhalers-treat-lung-]


==Short-Course/Workshop Instructor==
==Short-Course/Workshop Instructor==
1.Aerosol School 2-Day Workshop: ''"Aerosol Science Fundamentals and Inhalation Aerosol Delivery''", NIH-NCI Cancer Nanotechnology Training Center (CNTC),  April 17-18 2012.
1.Aerosol School 2-Day Workshop Creator & Instructor: ''"Aerosol Science Fundamentals and Inhalation Aerosol Delivery''", NIH-NCI Cancer Nanotechnology Training Center (CNTC),  April 17-18 2012.
 
2.Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Course Instructor. Invited Presentation Title: ''"Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery.''" 2012. [http://www.niroinc.com/pdfs/news/spray_drying_course_flyer_2012.pdf]
 
3.Buchi Hands-On Spray Drying Course, Newark, DE. Course Instructor. Invited Presentation Title: ''"Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying.''" 2014. [http://www.buchi.com/en/node/1689]
 
4.ISAM Aerosol School, Firestone Institute for Respiratory Health & McMaster University, Hamilton, Ontario, Canada. Faculty. 2016. [http://aerosolschool.com/index.html]
 
==Journal Publications==
 
 
'''== 2001-2009 =='''
 
1. '''Mansour H.''', Wang D.-S., Chen C.-S., and Zografi G. ''Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol.'' [[Langmuir]] (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.457)[http://pubs.acs.org/doi/abs/10.1021/la0108454]
 
2. '''Mansour, H.M.''' and Zografi G. ''The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions.'' [[Journal of Pharmaceutical Sciences]] (2007) 96 (2) February: 377-396. (Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20810/abstract]
 
3. '''Mansour, H.M.''' and Zografi G. ''Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers  and Monolayers at the Air-Water Interface.'' [[Langmuir]] (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.457)[http://pubs.acs.org/doi/abs/10.1021/la063053o]
 
4. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1282-1301. (Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20916/pdf]
 
5. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1302-1319. (Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20943/pdf]


==Journal Publications *Corresponding Author* ==
6. '''Mansour, H.M.''' and Hickey, A.J. ''Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review.'' [[AAPS PharmSciTech]] (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.641)[http://www.springerlink.com/content/q457w76780538w54/]
1. '''Mansour H.''', Wang D.-S., Chen C.-S., and Zografi G. ''Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol.'' [[Langmuir]] (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.268)[http://pubs.acs.org/doi/abs/10.1021/la0108454]


2. '''*Mansour, H.M.*''' and Zografi G. ''The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions.'' [[Journal of Pharmaceutical Sciences]] (2007) 96 (2) February: 377-396. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20810/abstract]
7. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[Respiratory Drug Delivery]] (2008) 3: 897-900. [http://www.rddonline.com/publications/articles/article.php?ArticleID=1265&return=1]


3. '''*Mansour, H.M.*''' and Zografi G. ''Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers  and Monolayers at the Air-Water Interface.'' [[Langmuir]] (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.268)[http://pubs.acs.org/doi/abs/10.1021/la063053o]
8. '''Mansour H.M.''', Damodaran S., and Zografi G.'' Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery.'' [[Molecular Pharmaceutics]] (2008) 5 (5) October 6: 681-695. (Impact Factor: 4.384)[http://pubs.acs.org/doi/abs/10.1021/mp700123p]


4. '''*Mansour H.M.*''', Damodaran S., and Zografi G.'' Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery.'' [[Molecular Pharmaceutics]] (2008) 5 (5) October 6: 681-695. (Impact Factor: 5.408)[http://pubs.acs.org/doi/abs/10.1021/mp700123p]
9. '''Mansour, H.M.''', Rhee, Y.S., and Wu, X. ''Nanomedicine in Pulmonary Delivery.'' [[International Journal of Nanomedicine]] (2009) 4 December: 299-319.(Impact Factor: 4.383)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802043/pdf/ijn-4-299.pdf]


5. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1282-1301. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20916/abstract]


6. Hickey, A.J., '''Mansour, H.M.''', et al. ''Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics.'' [[Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue]] (2007) 96 (5) May: 1302-1319. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.20943/abstract]
'''== 2010 =='''


7. '''*Mansour, H.M.*''' and Hickey, A.J. ''Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review.'' [[AAPS PharmSciTech]] (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.445)[http://www.aapspharmscitech.org/articles/pt0804/pt0804099/pt0804099.pdf]
10. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22107/abstract]


8. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[Respiratory Drug Delivery]] (2008) 3: 897-900. [http://www.rddonline.com/publications/articles/article.php?ArticleID=1265&return=1]
11. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22100/abstract]


9. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22107/abstract]
12. '''Mansour, H.M.''', Xu, Z., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March12; 3430-3441.(Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22101/abstract]


10. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22100/abstract]
13. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 2.590)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22057/abstract]


11. '''Mansour, H.M.''', Xu, Z., and Hickey, A.J. ''Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March12; 3430-3441.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22101/abstract]
14. '''Mansour, H.M.''', Sohn, M., Al-Ghananeem, A., and DeLuca P.P. ''Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper.'' [[International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications.]] (2010) 11: 3298-3322. (Impact Factor: 2.862)[http://www.mdpi.com/1422-0067/11/9/3298/pdf]


12. Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance.'' [[Journal of Pharmaceutical Sciences]] (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 3.031)[http://onlinelibrary.wiley.com/doi/10.1002/jps.22057/abstract]
15. Rhee, Y.S., Park, C.W., DeLuca, P.P., and '''Mansour, H.M.''' ''Sustained-Release Injectable Drug Delivery Systems. An Invited Paper.'' [[Pharmaceutical Technology: Special Issue-Drug Delivery]] (2010) November: 6-13. [http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Sustained-Release-Injectable-Drug-Delivery/ArticleStandard/Article/detail/694429?contextCategoryId=43497]


13. Xu, Z., '''Mansour, H.M.''', and Hickey, A.J. ''Particle Interactions in Dry Powder Inhaler Unit Processes.'' [[Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences]] (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[http://www.ingentaconnect.com/content/vsp/ast/2011/00000025/F0020004/art00009]
16. Hayes, D. Jr.,  Zwischenberger, J.B., and '''Mansour, H.M.''' ''Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient.'' [[Transplantation Proceedings]] (2010) 42 (9) November: 3876-3879.(Impact Factor: 1.061) [http://www.transplantation-proceedings.org/article/S0041-1345%2810%2901240-6/abstract]


14. '''*Mansour, H.M.*''' ''It's Only Natural: Using Polymers in Drug Delivery.'' [[Pharmaceutical Technology]] (2009) 33 (1) January: 1-2. [http://pharmtech.findpharma.com/pharmtech/Article/Its-Only-Natural-Using-Polymers-in-Drug-Delivery/ArticleStandard/Article/detail/576273]
17. Wu, X., Li, X., and  '''Mansour, H.M.''' ''Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper.'' [[KONA Powder and Particle Journal]] (2010) 28: 3-19/ (Impact Factor: 1.227) full text[https://www.jstage.jst.go.jp/article/kona/28/0/28_2010005/_pdf] [https://www.jstage.jst.go.jp/article/kona/28/0/28_2010005/_article]


15. '''*Mansour, H.M.*''', Rhee, Y.S., and Wu, X. ''Nanomedicine in Pulmonary Delivery.''  [[International Journal of Nanomedicine]] (2009) 4 December: 299-319.(Impact Factor: 4.976)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802043/pdf/ijn-4-299.pdf]


16. '''*Mansour, H.M.*''', Sohn, M., Al-Ghananeem, A., and DeLuca P.P. ''Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper.'' [[International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications.]]  (2010) 11: 3298-3322.  (Impact Factor: 2.279)[http://www.mdpi.com/1422-0067/11/9/3298/pdf]
'''== 2011 =='''


17. Rhee, Y.S., Park, C.W., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Sustained-Release Injectable Drug Delivery Systems. An Invited Paper.'' [[Pharmaceutical Technology: Special Issue-Drug Delivery]] (2010) November: 6-13. [http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Sustained-Release-Injectable-Drug-Delivery/ArticleStandard/Article/detail/694429?contextCategoryId=43497]
18. Xu, Z., '''Mansour, H.M.''', and Hickey, A.J. ''Particle Interactions in Dry Powder Inhaler Unit Processes.'' [[Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences]] (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[http://www.tandfonline.com/doi/abs/10.1163/016942410X525669#.U3KibigggWk]


18. Hayes, D. Jr.,  Zwischenberger, J.B., and '''Mansour, H.M.''' ''Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient.'' [[Transplantation Proceedings]] (2010) 42 (9) November: 3876-3879. [http://www.transplantation-proceedings.org/article/S0041-1345%2810%2901240-6/abstract]
19. Rhee, Y.S. and '''Mansour, H.M.''' ''Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 84-114.(Impact Factor: 1.144)[http://www.inderscience.com/search/index.php?action=record&rec_id=37172]


19. Wu, X., Li, X., and '''*Mansour, H.M.*''' ''Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper.'' [[KONA Powder and Particle Journal]] (2010) 28: 3-19. [http://www.kona.or.jp/search/28_003.pdf]
20. Wu, X. and '''Mansour, H.M.''' ''Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 115-145. (Impact Factor: 1.144)[http://www.inderscience.com/search/index.php?action=record&rec_id=37173&prevQuery=&ps=10&m=or]


20. Rhee, Y.S. and '''*Mansour, H.M.*''' ''Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 84-114.[http://www.inderscience.com/search/index.php?action=record&rec_id=37172]
21. Wu, X.,and '''Mansour, H.M.''' ''Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper.'' [[Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems.]] (2011)10 (3): 215-229. [http://www.benthamdirect.org/pages/b_viewarticle.php]


21. Wu, X. and '''*Mansour, H.M.*''' ''Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine. Invited Paper.'' [[International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals.]] (2011) 8 (1/2): 115-145. (Impact Factor: 1.329)[http://www.inderscience.com/search/index.php?action=record&rec_id=37173&prevQuery=&ps=10&m=or]
22. Park, C.W., Hayes, D. Jr., and '''Mansour, H.M.''' ''Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery.'' [[European Pharmaceutical Review.]] (2011) 16 (1): 32-36.[http://www.europeanpharmaceuticalreview.com/5627/european-pharmaceutical-review-magazine/past-issues/issue-1-2011/pulmonary-inhalation-aerosols-for-targeted-antibiotics-drug-delivery/]


22. Wu, X.,and '''*Mansour, H.M.*''' ''Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper.'' [[Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems.]] (2011)10 (3): 215-229. [http://www.benthamdirect.org/pages/b_viewarticle.php]
23. '''Mansour, H.M.''' ''Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper.'' [[Journal of the American Chemical Society.]] (2011) 133 (13): 5162. (Impact Factor: 9.907) [http://pubs.acs.org/doi/pdf/10.1021/ja202080e]


23. Park, C.W., Hayes, D. Jr., and '''*Mansour, H.M.*''' ''Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery. Invited Paper & Cover Page.'' [[European Pharmaceutical Review.]] (2011) 16 (1): 32-36.[http://www.europeanpharmaceuticalreview.com/tag/heidi-m-mansour/]
24. Hayes, D. Jr and '''Mansour, H.M.''' ''Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure.'' [[Lung.]] (2011) 189 (5): 409-415. (Impact Factor: 2.271)[http://www.springerlink.com/content/91526h6151744122/abstract/] [http://www.box.com/shared/ff53m3vfqy745tdr4un6]


24. '''*Mansour, H.M.*''' ''Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper.'' [[Journal of the American Chemical Society.]] (2011) 133 (13): 5162. (Impact Factor: 9.019) [http://pubs.acs.org/doi/pdf/10.1021/ja202080e]
25. Hayes, D. Jr., Ball, A.M., '''Mansour, H.M.''', Martin, C.A.,and Flynn, J.D. ''Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole.'' [[Experimental and Clinical Transplantation]] (2011)9 (6): 399-404. [http://www.ectrx.org/forms/ectrxcontentshow.php?year=2011&volume=9&issue=6&supplement=0&makale_no=0&spage_number=399&content_type=PDF].


25. Hayes, D. Jr and '''Mansour, H.M.''' ''Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure.'' [[Lung.]] (2011) 189 (5): 409-415. (Impact Factor: 1.734)[http://www.springerlink.com/content/91526h6151744122/abstract/] [http://www.box.com/shared/ff53m3vfqy745tdr4un6]
26. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and '''Mansour, H.M.''' ''Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres.'' [[AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.]](2011)12 (4):1293-1301. (Impact Factor: 1.641)[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225556/pdf/12249_2011_Article_9693.pdf] [http://www.box.com/shared/6xo6dozy3aphdc111dsi]


26. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres.'' [[AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.]](2011)12 (4):1293-1301. (Impact Factor: 1.445)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9693-z] [http://www.box.com/shared/6xo6dozy3aphdc111dsi]
27. Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery.'' [[AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing]] (2011)12(4):1420-1430. (Impact Factor: 1.641)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9704-0] [http://www.box.com/shared/0omofu03jsg2s5vs8yym]


27. DeLuca, P.P. and  '''*Mansour, H.M.*''' ''Insight Interview: Drug Delivery & Formulation-Controlled Release .'' [[World Pharmaceutical Frontiers]] (2011)2(September): 61-64.[http://www.worldpharmaceuticals.net/editorials/020/WPF020_ready-to-take-off.pdf]


28. Li, X. and  '''*Mansour, H.M.*''' ''Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery.''  [[AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing]] (2011)12(4):1420-1430. (Impact Factor: 1.445)[http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-011-9704-0] [http://www.box.com/shared/0omofu03jsg2s5vs8yym]
'''== 2012 =='''


29. Hayes, D. Jr., Ball, A.M., '''Mansour, H.M.''', Martin, C.A.,and Flynn, J.D. ''Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole.'' [[Experimental and Clinical Transplantation]] (2011)9 (6): 399-404. [http://www.ectrx.org/forms/ectrxcontentshow.php?year=2011&volume=9&issue=6&supplement=0&makale_no=0&spage_number=399&content_type=PDF].
28. Hayes, D. Jr., Winkler, M.A., Kirkby, S., Capasso, P., '''Mansour, H.M.''' and Attili, A.K. ''Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis.'' [[Lung]] (2012)190 (2)April:221-225.(Impact Factor: 2.271)[http://www.springerlink.com/content/y761114p7m62451m/]


30. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and '''*Mansour, H.M.*''' ''Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper.'' [[Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery.]] (2012) 64 (4) March 30: 344-356. (Impact Factor: 13.577)[http://www.sciencedirect.com/science/article/pii/S0169409X11002298]
29. Hayes, D. Jr. and '''Mansour, H.M.''' ''Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation.'' [[Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association]] (2012)16(8):333-337. [Impact Factor: 1.441][http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3046.2012.01682.x/abstract]


31. Willis, M.L., Hayes, D Jr., and '''*Mansour, H.M.*''' ''Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery.'' [[Lung]] (2012) 190 (3): 251-262.(Impact Factor: 1.734)[http://www.springerlink.com/content/a833780030np6468/] [http://www.box.com/shared/2027z21x6myctpztvsk0]
30. Hayes, D. Jr., '''Mansour, H.M.''', Kirkby, S., and Phillips, A.B. ''Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection." [[Transplant Infectious Diseases]] (2012)14 (5): 548-550. [Impact Factor: 2.064][http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3062.2012.00748.x/abstract;jsessionid=B6A3A133BAFC963F559C344343F14F9F.d03t04]


32. Duan, J.H., '''Mansour, H.M.''', Zhang, Y.D., Deng, X.M., Zhao, J.F. ''Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles.'' [[International Journal of Pharmaceutics]] (2012) 426 (1-2): 193-201. (Impact Factor: 3.607)[http://www.sciencedirect.com/science/article/pii/S0378517312000543?v=s5]
31. Duan, J.H., '''Mansour, H.M.''', Zhang, Y.D., Deng, X.M., Zhao, J.F. ''Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles.'' [[International Journal of Pharmaceutics]] (2012) 426 (1-2): 193-201. (Impact Factor: 3.650)[http://www.sciencedirect.com/science/article/pii/S0378517312000543?v=s5]


33. Hayes, D. Jr., Winkler, M.A., Kirkby, S., Capasso, P., '''Mansour, H.M.''' and Attili, A.K. ''Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis.'' [[Lung]] (2012)190 (2)April:221-225.(Impact Factor: 1.734)[http://www.springerlink.com/content/y761114p7m62451m/]
32. Park, C.W., '''Mansour, H.M.''', Oh, T.O., Kim, J.Y., Ha, J.M., Lee, B.J., Chi, S.C., Rhee, Y.S., Park, E,S. "''Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications.''" [[International Journal of Pharmaceutics]] (2012) 436 (1-2):652-658.(Impact Factor: 3.650) [http://www.sciencedirect.com/science/article/pii/S0378517312007752]


34. Hayes, D. Jr. and '''Mansour, H.M.''' ''Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation.'' [[Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association]] (2012): 1-5. [Impact Factor: 1.873](IN PRESS)[http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3046.2012.01682.x/abstract]
33. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and '''Mansour, H.M.''' ''Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper.'' [[Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery.]] (2012) 64 (4) March 30: 344-356. (Impact Factor: 15.038)[http://www.sciencedirect.com/science/article/pii/S0169409X11002298]


35. Hayes, D. Jr., '''Mansour, H.M.''', Kirkby, S., and Phillips, A.B. ''Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection. Transplant Infectious Diseases.'' [[Transplant Infectious Diseases]] (2012): 1-3. [Impact Factor: 2.053] (IN PRESS)[http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291399-3062]
34. Willis, M.L., Hayes, D Jr., and '''Mansour, H.M.''' ''Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery.'' [[Lung]] (2012) 190 (3): 251-262.(Impact Factor: 2.271)[http://www.springerlink.com/content/a833780030np6468/] [http://www.box.com/shared/2027z21x6myctpztvsk0]


==Edited Book (co-Editor)==
35.'''Mansour, H.M.''' "''Aerosol Formulation Issues.''" [[Pediatric Pulmonology]] (2012) 47 (35):149-151. (Impact Factor: 2.297) [http://onlinelibrary.wiley.com/doi/10.1002/ppul.22681/abstract]
1. [[Nanomedicine in Drug Delivery]], Kumar, A., '''Mansour, H.M.''', Friedman, A., and Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, London, United Kingdom. 450 pages. [http://www.crcpress.com/product/isbn/9781466506169]
 
 
'''== 2013 =='''
 
36. Meenach, S.A. Vogt,F.G., Anderson, K.W., Hilt, J.Z., McGarry,R.C., and  '''Mansour, H.M.'''. ''Design, Physicochemical Characterization, and Optimization of Organic Solution Advanced Spray-Dried Inhalable Dipalmitoylphosphatidylcholine (DPPC) and Dipalmitoylphosphatidylethanolamine Poly(Ethylene Glycol) (DPPE-PEG) Microparticles and Nanoparticles for Targeted Respiratory Nanomedicine Delivery as Dry Powder Inhalation Aerosols.'' [[International Journal of Nanomedicine]] (2013) 8:275-293.(Impact Factor: 4.383)[http://www.dovepress.com/getfile.php?fileID=14947]
 
37. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer.'' [[European Journal of Pharmaceutical Sciences]] (2013) 49 (4): 699-711.(Impact Factor: 3.350)[http://www.sciencedirect.com/science/article/pii/S0928098713001917]
 
38. Wu,X., Hayes, D Jr., Zwischenberger, J.B., Kuhn, R.J., and '''Mansour, H.M.''' ''Design and Physicochemical Characterization of Advanced Spray-Dried Tacrolimus  Multifunctional Particles for Inhalation.'' [[Drug Design, Development, and Therapy]]  (2013) 7:59-72. (Impact Factor: 3.028) [http://www.dovepress.com/getfile.php?fileID=15100]
 
39. Wu,X., Zhang, W., Hayes, D Jr., and '''Mansour, H.M.''' ''Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Cyclosporine A Multifunctional Particles for Dry Powder Inhalation Aerosol Delivery.'' [[International Journal of Nanomedicine]] (2013) 8 :1269-1283.(Impact Factor: 4.383)[http://www.dovepress.com/getfile.php?fileID=15566]
 
40. Park, C.W., Li X., Vogt, F.G., Hayes, D. Jr., Zwischenberger, J.B., Park, E.S. and '''Mansour, H.M.''' ''Advanced Spray Dried Design, Physicochemical Characterization and Aerosol Dispersion Performance of Vancomycin and Clarithromycin Multifunctional Controlled Release Particles for Targeted Respiratory Delivery as Dry Powder Inhalation Aerosols..'' [[International Journal of Pharmaceutics]] (2013) 455 (1–2): 374–392.(Impact Factor: 3.785)[http://www.sciencedirect.com/science/article/pii/S0378517313005565]
 
41. Zheng Z, Zhang W, Sun W, Li X, Duan J, Cui J, Feng Z, and '''Mansour, H.M.''' ''Influence of the Carboxymethyl Chitosan Anti-Adhesion Solution on the TGF-β1 in a Postoperative Peritoneal Adhesion Rat.'' [[Journal of Materials Science: Materials in Medicine]] (2013) 24 (11): 2549-2559. (Impact Factor:  2.587) [http://link.springer.com/article/10.1007/s10856-013-4981-7]
 
42. Duan J.H., Vogt, F.G., Li X., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Physicochemical Characterization and Aerosolization of Organic Solution Advanced Spray Dried and Co-Spray Dried Moxifloxacin and Ofloxacin Dipalmitoylphosphatidylcholine (DPPC) Microparticulate/Nanoparticulate Powders for Pulmonary Inhalation Aerosol Delivery.'' [[International Journal of Nanomedicine]] (2013) 8: 3489-3505.  [http://www.dovepress.com/getfile.php?fileID=17495](Impact Factor: 4.383)
 
43. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013) 16 (3): 382-385. (Impact Factor: 1.441)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]
 
44. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013) 191 (4): 441-443. (Impact Factor: 2.271)[http://link.springer.com/article/10.1007%2Fs00408-013-9468-2]
 
45.Hayes, D. Jr., Daniels, C.J., '''Mansour, H.M.''', Kopp, B.T., Yates, A.R., McCoy, K.S., Patel, A.V., and Kirby, S. ''Right Heart Catherization Measuring Central Hemodynamics in Cystic Fibrosis During Exercise.'' [[Respiratory Medicine]] (2013): 107 (9): 1365–1369. [Impact Factor: 3.086][http://www.sciencedirect.com/science/article/pii/S0954611113002096]


==Book Chapters  *Corresponding Author*==
46. Hayes, D. Jr., Daniels, C.J., '''Mansour, H.M.''', Kopp, B.T., Yates, A.R., Preston, T., and Kirby, S. ''Identification of the Nodose Ganglia and TRPV1 in Swine.'' [[Lung]] (2013): 191(5):445-447(Impact Factor: 2.271)[http://link.springer.com/content/pdf/10.1007%2Fs00408-013-9496-y.pdf]
1. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols.'' [[Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series]], Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. [http://informahealthcare.com/doi/abs/10.3109/9781420045260.043?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


2. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Chapter 5: Delivery of Drugs by the Pulmonary Route.'' [[Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,]] Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. [http://informahealthcare.com/doi/abs/10.3109/9781420065688.005?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]
47.Hayes, D Jr., Kirkby, S., McCoy, K.S., '''Mansour, H.M.''', Khosravi, M., Strawbridge, H., and Tobias, J.D.  ''Reduction of Lipid-Laden Macrophage Index After Laproscopic Nissen Fundoplication in Cystic Fibrosis Patients After Lung Transplantation.'' [[Clinical Transplantation]] (2013) 27 (1): 121-125.(Impact Factor: 1.522) [http://onlinelibrary.wiley.com/doi/10.1111/ctr.12020/abstract]


3. '''*Mansour, H.M.*''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]


4. '''*Mansour, H.M.*''', Park, C.W., and Bawa, R. Book Volume 1, ''Chapter: Design and Development of Approved Nanopharmaceutical Products.'' [[Clinical Nanomedicine: from Bench to Bedside. Series in Nanomedicine]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press, Boca Raton, FL, (2012): pp. 1-27.
'''== 2014 =='''


5.'''*Mansour, H.M.*''', Park, C.W., and Hayes, D. Jr. ''Book Chapter: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor Francis, Inc., London, United Kingdom (2012). [http://www.crcpress.com/product/isbn/9781466506169]
48. Hayes, D. Jr., Yates, A.R., Duffy, V., Tobias, J., '''Mansour, H.M.''', Olshove, V., and Preston, T.J. ''Rapid placement of bicaval dual-lumen catheter in a swine model of venovenous ECMO.'' [[Journal of Investigative Surgery]] (2014): 27(1):27-31. [Impact Factor: 1.158] [http://informahealthcare.com/doi/abs/10.3109/08941939.2013.826311]


6. '''*Mansour, H.M.*''' and Park, C.W. ''Book Chapter: Therapeutics and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.'' [[The Clinical Nanomedicine Handbook.]] CRC Press, Inc., London, United Kingdom (2012). [http://www.crcpress.com/product/isbn/9781439834787]
49. Hayes, D. Jr., Adler, B., Turner, T.L., and '''Mansour, H.M.'''. ''Alternative Tacrolimus and Sirolimus Regimen Associated with Rapid Resolution of Posterior Reversible Encephalopathy Syndrome After Lung Transplantation.'' [[Pediatric Neurology]] (2014) 50: 272-275.(Impact Factor: 1.695)[http://www.sciencedirect.com/science/article/pii/S0887899413006693]


7.'''*Mansour, H.M.*''', Park, C.W., Rhee, Y.S., and DeLuca, P.P. ''Book Chapter: Novel Drug Delivery Systems.'' [[Drug Delivery.]] Mitra, A.K. (Editor), First Edition,  Jones & Bartlett, Burlington, MA. (2012).
50. Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray Dried Microparticulate/Nanoparticulate Antibiotic Dry Powders of Tobramycin and Azithromycin for Pulmonary Inhalation Aerosol Delivery.'' [[European Journal of Pharmaceutical Sciences]] (2014) 15: 191-205. (Impact Factor: 3.350) [http://elsarticle.com/1ej23qD]


== Professional Memberships==
51.Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[Journal of Aerosol Medicine & Pulmonary Drug Delivery]] (2014): 27 (2):81-93. (Impact Factor: 2.798)[http://online.liebertpub.com/doi/pdfplus/10.1089/jamp.2013.1078]
* Academy of Pharmaceutical Sciences of Great Britain
* American Association for Aerosol Research
* American Association of Colleges of Pharmacy
* American Association of Pharmaceutical Scientists
* American Chemical Society
* American Pharmacists Association
* American Society of Nanomedicine
* Controlled Release Society
* European Federation for Pharmaceutical Sciences
* European Cystic Fibrosis Society
* Golden Key
* International Association of Colloid and Interface Scientists
* International Liposome Society
* International Microencapsulation Society
* International Pharmaceutical Federation
* International Society for Aerosols in Medicine
* Phi Eta Sigma
* Phi Kappa Phi
* Rho Chi
* United States Pharmacopeia (USP)-UK COP Delegate


==Research Lab Group Members==
52. Li X., Vogt, F.G., Hayes, D. Jr., and '''Mansour, H.M.''' ''Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Co-Spray Dried Antibiotics with Mannitol as Respirable Microparticles/Nanoparticles for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[Journal of Pharmaceutical Sciences]] (2014)103(9): 2937-2949. [Impact Factor: 2.590][http://onlinelibrary.wiley.com/doi/10.1002/jps.23955/abstract]
1. Dr. Yun-Seok Rhee, Ph.D., Postdoctoral Research Scholar


2. Dr. Xiao Wu, Ph.D., Postdoctoral Research Scholar
53.  Muralidharan, P., Mallory, E., Malapit, M., Hayes, D. Jr., and '''Mansour, H.M.''' ''Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers.'' [[Pharmaceutics: Special Issue: Liposomal Technologies (Guest Editor: Prof. Timothy D. Heath, UW-Madison) ]] (2014) 6 (2): 333-353. [http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned] [http://www.mdpi.com/1999-4923/6/2/333/pdf]


3. Dr. Chun-Woong Park, Ph.D., Postdoctoral Research Scholar
54. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies.'' [[AAPS PharmSciTech]]  (2014)15(6) December:1574-1587. [Impact Factor: 1.641] [http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12249-014-0182-z]  [http://link.springer.com/article/10.1208/s12249-014-0182-z]


4. Dr. Jinghua Duan, Ph.D., Postdoctoral Research Scholar
55. Hayes, D. Jr., Tobias, J.D., '''Mansour, H.M.''', Kirkby, S., McCoy, K.S., Daniels, C.J., and Whitson, B.A. ''Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease.'' [[American Journal of Respiratory and Critical Care Medicine]] (2014) 190 (8):898-905. [Impact Factor: 12.996] [http://www.atsjournals.org/doi/abs/10.1164/rccm.201407-1382OC?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed] <BR>
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [http://f1000.com/prime/718875747?bd=1&ui=22079]


5. Dr. Samantha Meenach, NIH NCI CNTC Postdoctoral Fellow


6. Dr. Wei Fen Zhang, Visiting Professor
'''== 2015 =='''


7. Dr. Scott Silva, Ph.D., M.D.,Postdoctoral Research Fellow & Physician Scientist
56. Stocke, N., Meenach, S.A.,Arnold, S.M., '''Mansour, H.M.*''',and Hilt, J.Z.  ''Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery via Spray Drying.'' [[International Journal of Pharmaceutics]] (2015) 479 (2): 320–328. '''*'''Corresponding Authors [Impact Factor: 3.650] [http://www.sciencedirect.com/science/article/pii/S0378517314009478]


8. MinJi Sohn, M.S., Visiting Graduate Student Research Scholar
57. Hayes, D. Jr., McCoy, K.S., Whitson, B.A., '''Mansour, H.M.''' , and Tobias, J.D.  ''High-Risk Age Window for Mortality in Children with Cystic Fibrosis after Lung Transplantation.''  [[Pediatric Transplantation]] (2015)19(2):206-210.(Impact Factor: 1.441)[http://onlinelibrary.wiley.com/doi/10.1111/petr.12401/abstract]


9. Xiaojian Li, M.S., Doctoral Candidate (Dissertator) & Center of Membrane Sciences Fellow
58. Hayes, D. Jr., Black, S.M., Tobias, J.D., '''Mansour, H.M.''', and Whitson, B.A. ''Influence of pulmonary hypertension on survival in advanced lung disease.'' [[Lung]] (2015)193(2):213-21. [Impact Factor: 2.271][http://link.springer.com/article/10.1007/s00408-015-9696-8]


10. Lauren Willis, Pharm.D. Student Researcher
59. Muralidharan, P., Hayes, D. Jr., and '''Mansour, H.M.''' ''Dry Powder Inhalers in COPD, Lung Inflammation, and Pulmonary Infections.'' [[Expert Opinion on Drug Delivery]] (2015) 12 (6): 947-962. (Impact Factor: 4.840)[http://informahealthcare.com/doi/abs/10.1517/17425247.2015.977783][http://informahealthcare.com/doi/pdf/10.1517/17425247.2015.977783]


11. Amber Jerke, NSF-REU Research Fellow
60. Muralidharan, P., Malapit, M., Mallory, E., Hayes, D. Jr., and '''Mansour, H.M.''' ''Inhalable Nanoparticulate Powders for Respiratory Delivery.'' [[Nanomedicine: Nanotechnology, Biology, and Medicine]] (2015)11:1189-1199. [Impact Factor: 6.155][http://www.nanomedjournal.com/article/S1549-9634%2815%2900031-3/abstract][http://www.nanomedjournal.com/article/S1549-9634(15)00031-3/pdf]


12. Charles Ritchie, HPLC Research Technician
61.Hayes, D. Jr., Kirkby, S., Whitson, B.A., Black, S.M., Sheikh, S.I., Tobias, J.D., '''Mansour, H.M.''', and Kopp, B.T. ''Mortality Risk and Pulmonary Function in Adults with Cystic Fibrosis at Time of Wait Listing for Lung Transplantation.'' [[The Annals of Thoracic Surgery]] (2015) 100(2): pp. 474-479.  [Impact Factor: 3.849][http://www.sciencedirect.com/science/article/pii/S0003497515006256]


13.Wei Qui, Animal Research Technician
62.Hayes, D. Jr., Whitson, B.A., Ghadiali, S.N., Lloyd, E.A., Tobias, J.D., '''Mansour, H.M.''', and Black, S.M. ''Survival in Adult Lung Transplant Recipients Receiving Pediatric vs. Adult Donor Allografts.''  [[The Annals of Thoracic Surgery]] (2015)100(4):1211-6.[Impact Factor: 3.849][http://www.sciencedirect.com/science/article/pii/S0003497515007894]


==Co-Advisor Lab Group Members==
63.Hayes, D. Jr., Patel, A.V., Black, S.M., McCoy, K.S., Kirkby, S.,Tobias, J.D., '''Mansour, H.M.''', and Whitson, B.A. ''Influence of diabetes on survival in cystic fibrosis before and after lung transplantation.'' [[The Journal of Thoracic and Cardiovascular Surgery]] (2015)150(3):707-713. [Impact Factor: 4.168][http://www.sciencedirect.com/science/article/pii/S002252231501065X]<BR>
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [http://f1000.com/prime/725756020?subscriptioncode=313a7e6a-884f-4e57-b55d-27a50de0b505]


1. Nathanael Stocke, NSF-IGERT Fellow, College of Engineering
64. Lu, Q., Harris, V.A., Kumar, S., '''Mansour, H.M.''', and Black, S.M. ''Autophagy in Neonatal Hypoxia Ischemic Brain is Associated with Oxidative Stress.'' [[Redox Biology]] (2015)6:516-523.[http://www.sciencedirect.com/science/article/pii/S2213231715000671][http://www.sciencedirect.com/science/article/pii/S2213231715000671/pdfft?md5=2b88c245799079147cf1643f87b8be46&pid=1-s2.0-S2213231715000671-main.pdf]


2. Alexander McKinlay, NSF-REU Fellow, Department of Biomedical Engineering
65. Hayes, D. Jr., Whitson, B.A., Ghadiali, S.N., Tobias, J.D., '''Mansour, H.M.''', and Black, S.M. ''Influence of HLA Mismatching on Survival in Lung Transplantation.''[[Lung]] (2015)193 (5):789-797.[Impact Factor: 2.271] [http://link.springer.com/article/10.1007/s00408-015-9768-9]


== Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)*Presenting Author* ==
66. Hayes, D. Jr., Kopp, B.T.,Tobias, J.D., Woodley, F.W., '''Mansour, H.M.''', Tumin D., and Kirkby, S.E.  ''Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation.''[[Lung]] (2015)193(6):933-8.[Impact Factor: 2.271] [http://link.springer.com/article/10.1007%2Fs00408-015-9811-x]


1.'''*Mansour, H.M.*''', Damodaran, S., and Zografi, G. ''Surface Structural Characterization and Effects of a Surface-Active, Hydrophobic Heteropolypeptide, KL4, on Phospholipid Bilayer Spreading and Monolayer Phase Behavior at the Air-Water Interface:  Implications for Pulmonary Surfactant Delivery.'' [[The 10th Annual Liposome Research Days & The 1st Univ. of North Carolina Drug Conference]], Chapel Hill, NC, 2006.


2.'''*Mansour, H.M.*''', Kujanpää, J., Tuomenoja, H., Papadopoulos, D., Mulder, T., Langridge, J., and Hickey, A.J.  ''Characterization of the Effects of Various Sugar Carriers and Inhalation Devices on the Surface Electrostatics of Aerosolized Dry Powder Inhalation Particles containing Albuterol Sulfate.''  [[The AAPS Journal]] (2006) 8 (S2) M1239.
'''== 2016 =='''


3.'''*Mansour, H.M.*''', Kujanpää, J., Tuomenoja, H., and Hickey, A.J.  ''Electrostatic Charge Behavior of Aerosolized Pharmaceutical Particles for Various Drug/Sugar Carrier Dry Powder Inhalation Particulate Systems.'' [[The AAPS Journal]] (2006) 8 (S2) M1245.  
67.Hayes, D. Jr., Black, S.M., Tobias, J.D., Kirkby, S., '''Mansour, H.M.''', and Whitson, B.A. ''Influence of Pulmonary Hypertension on Patients with Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation.'' [[The Annals of Thoracic Surgery]] (2016) 101(1):246-52. [Impact Factor: 3.849][http://www.sciencedirect.com/science/article/pii/S0003497515010322]


4.'''*Mansour, H.M.*''', Xu, Z., and Hickey, A.J.  ''Characterization of Dry Powder Aerosols of Albuterol Sulfate and Cromolyn Sodium with Various Sugar Carriers Delivered by Standardized Entrainment Tubes.'' [[The AAPS Journal]] (2007) 9 (S2) W5234.  
68. Hayes, D. Jr., Black, S.M., Tobias, J.D., '''Mansour, H.M.''', and Whitson, B.A. ''Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation.'' [[COPD: Journal Of Chronic Obstructive Pulmonary Disease]](2016) 13(1):50-6. [Impact Factor: 2.673] [http://informahealthcare.com/doi/abs/10.3109/15412555.2015.1043425]


5.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J.  ''Characterization of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes.'' [[The AAPS Journal]] (2007) 9 (S2) W5235.  
69. Hayes, D. Jr., Younger, B.R., '''Mansour H.M.''', and Strawbridge, H. ''Precordial Catch Syndrome in Elite Swimmers with Asthma.'' [[Pediatric Emergency Care]] (2016) 32 (2):104-106.


6.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Performance Evaluation of Dry Powder Aerosol Formulation Using Modified Surface Adsorption Expression.'' [[The AAPS Journal]] (2009) (S2) R6197.
70. Hayes D Jr, Black SM, Tobias JD, Kopp BT, Kirkby SE, '''Mansour HM''', and Whitson BA. ''Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.'' [[The Journal of Heart and Lung Transplantation]](2016) (IN PRESS) [Impact Factor: 6.650][http://www.jhltonline.org/article/S1053-2498%2815%2901416-3/abstract]


7.Xu, Z., '''Mansour, H.M.''', Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. ''Heterogenous Particle Deaggregation and Its Implication for Therapeutic Aerosol Performance.'' [[The AAPS Journal]] (2009) (S2) R6198.
71. Hayes, D. Jr., Auletta, J.J., Whitson B.A., Black, S.M., Kirkby, S., Tobias, J.D., and '''Mansour H.M.'''  ''Human leukocyte antigen mismatching and survival after lung transplantation in adult and pediatric patients with cystic fibrosis.'' [[The Journal of Thoracic and Cardiovascular Surgery]] (2016)151(2):549-557.[Impact Factor: 4.168] [http://www.jtcvsonline.org/article/S0022-5223%2815%2901469-5/abstract]


8.'''Mansour, H.M.''', Sohn, M., Rhee, Y.S., Woo, B., and DeLuca P.P. ''Sustained Release Delivery of Octreotide Acetate from Biodegradeable Polymeric Microspheres.'' [[The AAPS Journal]] (2009) (S2) W5036.
72. Hayes, D. Jr., Tumin D., Daniels, C.J., McCoy, K.S., '''Mansour H.M.''', Tobias, J.D., and Kirkby, S. ''Pulmonary Artery Pressure and Benefit of Lung Transplantation in Adult Cystic Fibrosis Patients.'' [[The Annals Thoracic Surgery]](2016): 101(3):1104-1109. [Impact Factor: 3.849]


9.Jerke, A., Dziubla, T.D., and '''Mansour, H.M.''' ''Physical and Chemical Characterization of Various Pulmonary Drugs and Sugars for Targeted Pulmonary Delivery.'' [[NSF-REU Summer Research Symposium]], University of Kentucky College of Engineering, Lexington, KY (July 2009)
73. Acosta, M., Muralidharan, P, Meenach, S.A., Hayes, D. Jr., Black, S.M., and '''Mansour, H.M.''' ''In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models.'' [[Current Pharmaceutical Design]](2016)22: (IN PRESS) [Impact Factor: 3.452][http://benthamscience.com/journals/current-pharmaceutical-design/article/139025/]


10.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[NSF-IGERT Spring Research Symposium]], University of Kentucky College of Engineering, Lexington, KY (May 2010)
74. Muralidharan, P, Hayes, D. Jr., Black, S.M., and '''Mansour, H.M.''' ''Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway.'' [[The Royal Society of Chemistry(RSC): Molecular Systems Design & Engineering]](2016): 1-18.DOI: 10.1039/C5ME00004A [http://pubs.rsc.org/en/journals/journalissues/me#!recentarticles&adv]


11.Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Sorption of Advanced Spray Dried Trehalose Microparticles and Nanoparticles in the Solid-State for Targeted Pulmonary Delivery as Dry Powders.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
75. Muralidharan, P, Acosta, M., Hayes, D. Jr., Black, S.M., and '''Mansour, H.M.''' ''Solid State Physicochemical Characterization & Microscopy of Particles in Dry Powder Inhalers.'' [[Inhalation]] (2016): (IN PRESS)


12.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
76. Rojo de la Vega, M., Dodson, M., Gross, C., '''Mansour, H.M.''', Lantz, R.C., Chapman, E., Wang, T., Black, S.M., Garcia, J.G.N., and Zhang, D. ''Role of Nrf2 and Autophagy in Acute Lung Injury.'' [[Current Pharmacology Reports: Free Radicals Medicine]] (2016) 2 (2): 91-101. [http://link.springer.com/content/pdf/10.1007%2Fs40495-016-0053-2.pdf][http://link.springer.com/article/10.1007%2Fs40495-016-0053-2]


13.Wu, X. and '''Mansour, H.M.''' ''Advanced Spray Dried Tacrolimus Particles for Lung Transplant Immunosuppression By Targeted Dry Powder Pulmonary Inhalation Delivery.'' [[Pharmaceutics Graduate Student Research Meeting (PGSRM)]]. The Ohio State University College of Pharmacy, Columbus, OH. (June 2010).
77. Meenach, S.A., Tsoras, A.N., McGarry, R.C., '''Mansour, H.M.''', Hilt, J.Z., and Anderson, K.W.  ''Development of Three-Dimensional Lung Multicellular Spheroids in Air- and Liquid-Interface Culture for the Evaluation of Anticancer Therapeutics.'' [[International Journal of Oncology]] (2016)48(4): 1701-1709. [Impact Factor: 3.025][http://www.spandidos-publications.com/10.3892/ijo.2016.3376]


14.Williamson, J. and '''Mansour, H.M.''' ''Advanced Co-Spray Dried Disodium Cromoglycate and Fluticasone Propionate Microparticles and Nanoparticles for Combination Drug Pulmonary Inhalation Delivery.'' [[UK COP SURP Research Symposium]], Lexington, KY (July 2010).
==Edited Book (co-Editor)==
1. [[Nanomedicine in Drug Delivery]], Kumar, A., '''Mansour, H.M.''', Friedman, A., and Blough, E. (Editors), CRC Press/Taylor & Francis, London, United Kingdom. (2013) 469 pages. ISBN: 9781466506169 [http://www.crcpress.com/product/isbn/9781466506169][http://books.google.com/books?hl=en&lr=&id=QWhSMfsn6tYC&oi=fnd&pg=PP1&dq=info:Lf0jl2sCR2EJ:scholar.google.com&ots=wxUAiFY--3&sig=tX2bBhGxBV0twoAczpmjuezUt2U#v=onepage&q&f=false][http://www.taylorandfrancis.com/books/details/9781466506169/]


15.Li, X. and '''Mansour, H.M.''' ''Physicochemical Characterization and Water Vapor Sorption of Advanced Spray Dried Trehalose Microparticles and Nanoparticles in the Solid-State for Targeted Pulmonary Delivery as Dry Powders.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
==Book Chapters==
1. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols.'' [[Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series]].728 pages. Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. ISBN: 9781420053555 [http://informahealthcare.com/doi/abs/10.3109/9781420045260.043?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


16.Li, X., Hayes, D. Jr., and '''Mansour, H.M.''' ''Comparison of Advanced Spray Dried Micro/Nanoparticulate Aerosols of Antibiotics, Tobramycin and Azithromycin, in the Solid-State for Cystic Fibrosis Treatment: I. Manufacture and Characterization.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
2. Hickey, A.J. and '''Mansour, H.M.''' Book Volume 2, ''Book Chapter 5: Delivery of Drugs by the Pulmonary Route.'' [[Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,]].500 pages. Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. ISBN: 9781420065664 [http://informahealthcare.com/doi/abs/10.3109/9781420065688.005?prevSearch=authorsfield%253A%2528Mansour%252C%2BHeidi%2BM.%2529&searchHistoryKey=]


17.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 306 pages. Moghis, A. (Editor), American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2012): pp.221-268.ISBN: 9780981893679 [https://aocs.personifycloud.com/PersonifyEbusiness/Store/ProductDetails.aspx?productId=112814]


18.Ma, J., Carlson, S., Saatman, K.E., and '''Mansour, H.M.''' ''Advanced Spray Dried PLGA Particles for Subcutaneous Delivery.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
4. '''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] 469 pages. Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), CRC Press/Taylor & Francis, Inc., London, United Kingdom.  (2013): pp.43-74. ISBN: 9781466506169 [http://www.crcpress.com/product/isbn/9781466506169] [http://books.google.com/books?hl=en&lr=&id=QWhSMfsn6tYC&oi=fnd&pg=PP1&dq=info:Lf0jl2sCR2EJ:scholar.google.com&ots=wxUAiFY--3&sig=tX2bBhGxBV0twoAczpmjuezUt2U#v=onepage&q&f=false][http://www.taylorandfrancis.com/books/details/9781466506169/]


19.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Particles for Targeted Pulmonary Inhalation Delivery as Dry Powders.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
5. '''Mansour, H.M.''' and Park, C.W. ''Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.'' [[The Clinical Nanomedicine Handbook.]] 365 pages. Brenner, S.A. (Editor), CRC Press/Taylor & Francis, Inc., London, United Kingdom.  (2013): pp.321-338. ISBN: 9781439834787 [http://www.crcpress.com/product/isbn/9781439834787]


20.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Delivery.'' [[UK COP Research Symposium on Drug Discovery & Development]], Lexington, KY (October 2010).
6. '''Mansour, H.M.''', Xu, Z., Meenach, S.A., Park, C.W., Rhee, Y.S., and DeLuca, P.P. ''Book Chapter 5: Novel Drug Delivery Systems.'' [[Drug Delivery.]] 550 pages. Mitra, A.K. (Editor), Jones & Bartlett, Burlington, MA. (2015): pp.71-107. ISBN-13: 9781284025682 [http://www.jblearning.com/catalog/9781284025682/]


21.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Targeted Dry Powder Microparticulate/Nanoparticulate Pulmonary Delivery in Bronchoalveolar Carcinoma by Therapeutic-Mucolytic Particles.'' [[UK Markey Cancer Research Day 2011]], Lexington, KY (March 2011).
7. '''Mansour, H.M.''', Muralidharan, P., and Hayes, D. Jr. ''Book Chapter 8b: Inhaled Nanoparticulate Systems: Composition, Manufacture, and Aerosol Delivery.'' [[The ISAM Textbook of Aerosol Medicine.]] Dhand, R. (Editor-in-Chief), Rothen-Rutishauser, B., and Hickey A.J. (Associate Editors), International Society of Aerosols in Medicine (ISAM)/Mary Ann Libert Publishing, Inc. Rochelle, NY. (2015): 353-394. [http://isam.org/index.php?option=com_content&view=article&id=65&Itemid=381]


22.Li, X. and '''*Mansour, H.M.*''' ''Quality-By-Design for Excipient Functionality: Advanced Spray-Dried Trehalose Microparticles and Nanoparticles for Targeted Pulmonary Inhalation Delivery.'' [[International Pharmaceutical Excipient Council (IPEC) Excipient Fest 2011]], Baltimore, MD. (Mansour, H. M. Presenting Author).
8. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 9: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside.]] 3000 pages. Bawa,R., Audette, G., and Rubinstein, I. (Editors), Pan Stanford Publishing/CRC Press/Taylor & Francis, Inc., Boca Raton, FL. (2016): 233-272. ISBN: 9789814316170 [http://www.crcpress.com/product/isbn/9789814316170]


23.Li, X., Hayes, D. Jr, and '''*Mansour, H.M.*''' ''Targeted Pulmonary Delivery by Multifunctional Microparticulate/Nanoparticulate Pharmaceutical Inhalation Aerosols for Cystic Fibrosis Combination Drug/Mucolytic Treatment.'' [[European Cystic Fibrosis Society (ECFS) Basic Science Conference 2011]] Tirrenia-Pisa, Italy. (Mansour, H.M. Presenting Author)
9. '''Mansour, H.M.''', Myrdal, P.B., Younis, U., Muralidharan, P., Hillery, A. M., and Hayes, D. Jr. ''Book Chapter 11: Pulmonary Drug Delivery.'' [[Drug Delivery: Fundamentals and Applications.]] 630 pages. Hillery, A.M. and Park, K. (Editors), Second Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2016): 249-277. ISBN 9781482217711[https://www.crcpress.com/product/isbn/9781482217742]


24.Park, C.W, Hayes, D. Jr., and '''Mansour, H.M.''' ''Advanced Spray-dried Vancomycin hydrochloride and Clarithromycin Particles for Targeted Pulmonary Inhalation Delivery as Dry Powders.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
== Professional Memberships==
1.Academy of Pharmaceutical Sciences of Great Britain (APSGB)


25.Li, X., Hayes, D. Jr, and '''Mansour, H.M.''' ''Advanced Spray Dried Microparticles/Nanoparticles of Antibiotics and a Mucolytic in the Solid-state for Cystic Fibrosis Treatment by Targeted Pulmonary Delivery.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
2.American Thoracic Society (ATS)


26.Ma, J., Dziubla, T.D., and '''Mansour, H.M.''' ''Advanced Spray Dried Particles for Targeted Pulmonary Delivery in Lung Cancer.'' [[Controlled Release Society Annual Meeting & Exhibition 2011]] National Harbor, MD.
3.American Pharmacists Association (APhA)[http://archive.aphafoundation.org/AM/customsource/donations/paveimages/Paver_Photo.asp?paverid=O33]


27.'''*Mansour, H.M.*''' ''Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine-An Interfacial and Colloidal Science Approach.'' [[242th American Chemical Society (ACS) 2011 Annual Meeting-ACS Colloid & Surfaces Symposium on Nanomedicine]].
4.American Chemical Society (ACS)


28.'''*Mansour, H.M.*''' ''Advanced Pulmonary Medicine by Targeted Pulmonary Inhalation Drug Delivery as Respirable Multifunctional Microparticles and Nanoparticles.'' [[2011 Gordon Research Conference (GRC)-Lung Development, Injury & Repair]], Rhode Island.
5.American Association of Pharmaceutical Scientists (AAPS)


29.'''*Mansour, H.M.*''' ''Phospholipid  Nanopharmaceuticals in Advanced Drug Delivery.'' [[2011 American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Symposium on “Phospholipids in Pharma and Cosmetics Applications"]], Cincinnati, OH.  (Symposium Speaker).
6.American Association of the Colleges of Pharmacy (AACP)


30.Stocke, N., '''Mansour, H.M.''', and Hilt, J.Z. ''Enhanced Transport of PEG-Based Magnetic Nanocomposites In Artificial Mucus Barriers.'' [[2011 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition,  "Nanoscale Science and Engineering Forum"]].
7.American Society for Nanomedicine (ASNM)


31. Li, X., Hayes, D. Jr, and '''Mansour, H.M.''' ''Advanced Spray-Dried Microparticulate/Nanoparticulate Powders for Cystic Fibrosis Treatment by Targeted Pulmonary Delivery.'' [[2011 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]].
8.Controlled Release Society (CRS)


32. '''*Mansour, H.M.*''', Park, C.W, Vogt, F.G., and Hayes, D. Jr. ''Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery''. [[4th Annual Nanotechnology & Nanomedicine Symposium]].
9.European Federation for Pharmaceutical Sciences (EUFPS)


33. McKinlay, A., Zou, Y., Millbrandt, T.,  '''Mansour, H.M.''', and Puleo, D.A.  ''Encapsulation of Vancomycin and Ketoprofen in PLGA Microspheres for Treating Bacterial Infection and Inflammation in Joints''.  [[NSF-REU Summer Research Symposium]], University of Kentucky College of Engineering, Lexington, KY.
10.International Pharmaceutical Federation (FIP) Board of Pharmaceutical Specialties


34.   McKinlay, A., Zou, Y., Millbrandt, T.,  '''Mansour, H.M.''', and Puleo, D.A. ''Encapsulation of Vancomycin and Ketoprofen for Treating Bacterial Infection and Inflammation in Joints''. [[2011 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition,  "Nanoscale Science and Engineering Forum"]].
11.European Respiratory Society (ERS)


35. '''*Mansour, H.M.*''', Li, X, and Hayes, D. Jr. ''TARGETED LUNG DELIVERY BY INHALABLE MULTIFUNCTIONAL MICROPARTICULATE/NANOPARTICULATE AEROSOLS FOR CYSTIC FIBROSIS COMBINATION DRUG/MUCOLYTIC TREATMENT.'' [[Pediatric Pulmonology Journal]] (2011) Supplement Issue 34: 346. (presentation at the 2011 North American Cystic Fibrosis Conference (NACFC) Annual Meeting & Exhibition), Anaheim, CA (November 2011).
12.International Society for Aerosols in Medicine (ISAM),Co-Chair, Drug Delivery:New Devices & Emerging Therapies Group


36. Duan, J. H., Park, C.W., Oz, H., Silva, S.R., McGarry, R.C., Dziubla, T.D., Moscow, J.A., and '''Mansour, H.M.'''  ''Targeted Pulmonary Inhalation Delivery of Radioprotectant Nanoparticles for Lung Radioprotection and Alveolar Pneumonitis Prevention.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012).
13.The Aerosol Society (Great Britain)


37. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.'''  ''Characterization and Optimization of Inhalable PEGylated Phospholipid Microparticles and Nanoparticles Containing Paclitaxel for Targeted Dry Powder Pulmonary Delivery.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012).
14.International Association of Colloid and Interface Scientists (IACIS)


38. Stocke, N., '''Mansour, H.M.''', and  Hilt, J.Z.  ''PEG-coated Magnetic Nanoparticles for Treatment of Lung Cancer.'' [[UK Markey Cancer Research Day 2012]], Lexington, KY (May 2012).
15.The Biochemical Society


39. Meenach, S.A., McGarry, R.C., Hilt, J.Z., Anderson, K.W., and '''Mansour, H.M.''' ''Advanced Spray Dried Microparticulate/Nanoparticulate Inhalable Polymeric Lipospheres Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer Treatment.'' [[39th Annual Controlled Release Society Meeting & Exhibition 2012]], Quebec, Canada (July 2012).
16.British Society for Nanomedicine


40.Hayes, D. Jr., Yates, A.R., Duffy, V.L., Chicoine, L.G., Nicol, K.K., '''Mansour, H.M.''', McConnell, P.I., Preston, T.J.  ''Placement of a Bicaval Dual-lumen Catheter in Piglets Using Anatomical Landmarks and Confirmation with Transthoracic Echocardiography Doppler Imaging in a Model of Single-Venous Venovenous Extracorporeal Membrane Oxygenation.'' [[CHEST 2012 Annual Meeting]], Atlanta, GA (October 2012).
17.British Thoracic Society


41. Hayes, D. Jr., Kopp, B.T., '''Mansour, H.M.''', Kirkby, S., Yates, A.R., McCoy, K.S.,  Daniels, C.J.  ''Exercise-induced Pulmonary Arterial Hypertension in Cystic Fibrosis.'' [[CHEST 2012 Annual Meeting]], Atlanta, GA (October 2012).
18. The Royal Society of Medicine (Respiratory Medicine)


42.Meenach, S.A., McGarry, R.C., Hilt, J.Z., Anderson, K.W., and '''Mansour, H.M.''' ''Characterization and Optimization of Inhalable PEGylated Phospholipid Microparticles and Nanoparticles Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer as Dry Powder Inhalers.'' [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012).
19. The Royal Society of Chemistry


43.Meenach, S.A., Tsoras, A.N., McGarry, R.C., '''Mansour, H.M.''' ,  Hilt, J.Z., and Anderson, K.W. ''Development of Three-Dimensional Lung Multicellular Spheroids in Air and Liquid Interface Culture for the Evaluation of Anti-Cancer Therapeutics.''  [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)
== Honor Societies (Elected Member)==
1. Phi Eta Sigma National Honor Society


44.Stocke, N., Meenach, S.A., Anderson, K.W., '''Mansour, H.M.''' , and  Hilt, J.Z. ''Inhalable Iron Oxide Nanocomposites for Hyperthermia Application to Treat Lung Cancer.''  [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)
2. Phi Kappa Phi National Honor Society


45. Stocke, N., Zhang, X., '''Mansour, H.M.''',  DeRouchey, J., and  Hilt, J.Z., ''Probe Diffusion in Poly(ethylene glycol)-based Hydrogels Studied by Fluorescence Correlation Spectroscopy – Effects of Synthesis Conditions on Mobility of Single Molecules.'' [[2012 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]],  Pittsburgh, PA (October 2012)
3. Golden Key International Honor Society


46. Li, X., Vogt, F.G., Hayes, D. Jr, and '''Mansour, H.M.''' ''Design and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Mucolytic Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]],  Chicago, IL. (October 2012)
4. Rho Chi Pharmaceutical Honor Society


47. Li, X., Vogt, F.G., Hayes, D. Jr, and '''Mansour, H.M.'''  ''Design and Aerosol Dispersion Performance of Organic Solution Advanced Co-Spray-Dried Multifunctional Microparticulate/Nanoparticulate Aerosol Formulations for Targeted Pulmonary Delivery as Dry Powder Inhalers.'' [[2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exhibition]],  Chicago, IL. (October 2012)
5. Sigma Xi Scientific Research Honor Society

Revision as of 10:17, 22 June 2016

Shalom Aleichem. Numen Lumen. Sursum. Lux libertas. Carpe Diem.



"The Leading Research University in the American Southwest" "Sursum"

Dr. Heidi Michaela Mansour, Ph.D.
The University of Arizona
College of Pharmacy, Dept. of Pharmacy Practice & Science
College of Medicine, Div. of Translational & Regenerative Medicine
The BIO5 Research Institute
1703 E. Mabel St., Office 434/Lab 435 Skaggs, Tucson, AZ 85721-0207.

Email: mansour@pharmacy.arizona.edu

Websites

Clinton Foundation Ambassador [1]

Smile Train Premier Circle [2]

Research & Education: [3]

Graduate College Faculty Member:[4]

Faculty Member, The BIO5 Research Institute: [5]

Affiliated Faculty Member, Institute of the Environment: [6]

Associate Member [7], NCI Comprehensive Cancer Center: [8]

Google Scholar Publications: [9] PubMed Publications: [10] LinkedIn Profile: [11] Research Gate Profile: [12]

College of Pharmacy: http://www.pharmacy.arizona.edu/visitors/college-of-pharmacy-facts

World Rankings in Pharmacy & Pharmacology (Global): http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=+faculty=+stars=false+search=

World Rankings in Pharmacy & Pharmacology (USA):http://www.topuniversities.com/university-rankings/university-subject-rankings/2014/pharmacy#sorting=rank+region=+country=257+faculty=+stars=false+search=

The University of Arizona: http://www.arizona.edu/about/highlights-rankings

The University of Arizona Medical Center: http://uanews.org/story/university-of-arizona-medical-center-again-a-u-s-news-best-hospital

Professor Mansour Links

1. University of Wisconsin-Madison, Dept. of Hebrew & Semitic Studies: [13] [14]
Rabbi Eli Mansour [15] Mansoura Jewish Business [16]

2. Tel Aviv University: [17] [18]

3. Harvard Medical School: [19]

4. Stanford University School of Medicine, Molecular Pharmacology: [20] [21]

5. Emory University School of Medicine: [22]

6. University of Texas Southwestern Medical Center: [23]

7. Case Western Reserve University School of Engineering: [24]

8. University of Colorado-Denver:[25][26]

9.University of Utah, Dept. of Molecular Biology & Human Genetics: [27] [28]

10.The University of Texas: [29]

11. United States Military Academy West Point: [30]

Education

Postdoctorate, University of North Carolina-Chapel Hill[31], School of Pharmacy[32], 1/2006-6/2008.

Postdoctorate, University of Wisconsin-Madison[33], School of Pharmacy[34][35], 2004.

Ph.D. Major-Pharmaceutical Sciences (Pharmaceutics & Drug Delivery), University of Wisconsin-Madison, School of Pharmacy, 12/2003.
Ph.D. Minor-Advanced Physical & Biophysical Interfacial Chemistry, University of Wisconsin-Madison, Department of Chemistry, 12/1999.

B.S.-Pharmacy (Distinction & Honors), University of Wisconsin-Madison, 5/1996.

Health Professional Licensure

Registered Pharmacist 8/1996-Present.

Research Program

Research in the Mansour lab focuses on the fundamental and applied aspects of surface and interfacial chemistry, nanotechnology, and particle engineering technologies in the design and optimization of advanced drug delivery systems. Multifunctional polymeric phospholipid (lipopolymeric) self-assemblies are optimized for targeted drug delivery, nanomedicine, and multifunctional microparticles and nanoparticles in the solid-state as dry powder inhalation aerosols in the targeted treatment and prevention of several pulmonary diseases. These microparticulate/nanoparticulate dry powders which are targeted directly to the lung as dry powder inhalers are biocompatible, biodegradable, mucopenetrating, and provide sustained drug release. We utilize various types of inhaler devices for both in vitro and in vivo rodent animal models. A systematic Quality-by-Design (QbD) approach in the solid-state is used and includes comprehensive physicochemical characterization, design of experiments (DOEs), performance modeling, and prediction. Pulmonary diseases with unmet medical needs that we investigate in vitro and in vivo include lung transplantation, lung cancer, infectious diseases, lung inflammatory fibrotic diseases, and autoimmune diseases. Our research program includes translational medicine, as exemplified by several successful collaborations with physician-scientists.

Editorial Advisory Board Member (EAB)& Scientific Advisor

1. Pharmaceutical Technology [36]

2. Recent Patents on Nanomedicine [37]

3. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [38]

4. Journal of Pharmaceutical Sciences-Scientific Advisor to the Editors [39] [40]

5. Austin Journal of Pulmonary and Respiratory Medicine [41]

National Expert Committees & Study Sections

1. NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Working Group

2. NIH/NIAID

3. NIH/NCI

4.NIH/NIBIB

5. American Association for the Advancement of Science (AAAS)

6. National Science Foundation

7. NIH, Center for Scientific Review (CSR), Oncology 2 - Translational Clinical ZRG1

8. NIH, CSR, Pediatric Formulations & Drug Delivery Systems Study Section ZRG1 ETTN-B 50 R

9. NIH, CSR, NIAID Study Section ZAI1 RRS-M (C3)

10. NIH, CSR, NIAID Study Section ZAI1 BP-A (C1)

11. NIH, CSR, Bioengineering Sciences & Technologies Integrated Review Group, NANO Study Section

12.NIH, CSR, NCI Innovative Cancer Nanotechnology Study Section 2015/10 ZCA1 TCRB-9 (O1) R

13. The Rutgers Brain Health Institute,Rutgers University-Newark and New Jersey Institute of Technology, Pilot Grant Program [42]

14. AZ Area Health Education Centers (AHEC) Faculty Development Research Grants Program

15.NIH, CSR, NCI Study Section

16.NSF Nano-Bio Phenomena and Processes in the Environment Program Study Panel

International Expert Peer Reviewer

1. Indo-US Science & Technology

2. Austrian Science Fund

3. German-Israeli Foundation (GIF) for Scientific Research and Development

4. Deutscher Akademischer Austauschdienst Dienst (DAAD)German International Academic Exchange Service

5. Catalent Applied Drug Delivery Institute

6. Cochrane Airways Group, NHS National Institute for Health Research, Great Britain [43]

7. Engineering Physical Sciences Research Council (EPSRC), Great Britain

8. Engineering and Physical Sciences Research Council (EPSRC), Research Councils, Great Britain

9. PRESTIGE Marie Curie Post-doc Fellowships Programme,The European Commission & Campus France, Paris, France

10.Biomedical Innovation Program, French National Research Agency, Paris, France

Honors/Awards/Fellowships

  • 2015, Fellow, The Royal Society of Medicine (London, GBR)
  • 2015, Elected Co-Chair, Drug Delivery: New Devices & Emerging Therapies Group,International Society for Aerosols in Medicine (ISAM)
  • 2010, Mercer School of Pharmacy Dept of Pharmaceutical Sciences, Pharmabeat 2010 Researcher of the Issue, Mercer University
  • 2007-2008, Post Doctoral Fellow Award in Pharmaceutics, PhRMA Foundation
  • 2007-2008, Post Doctoral Scholars Award for Research Excellence, Office of the Vice Chancellor, University of North Carolina at Chapel Hill
  • 2007, Post Doctoral Fellow Award in Research Excellence, American Association of Pharmaceutical Scientists (AAPS)
  • 2001, Walter F. Enz Award in Research Excellence in the Pharmaceutical Sciences, Pharmacia Upjohn Global Pharmaceutical Sciences
  • 2000-2002, PhRMA Advanced Predoctoral Fellow Award in Pharmaceutics, Pharmaceutical Researchers & Manufacturers of America (PhRMA) Foundation
  • 1999-2001, AFPE Predoctoral Fellow Award, American Foundation for Pharmaceutical Education (AFPE)
  • 1996, Merck Award in Excellence in Pharmacy, Merck
  • 1996, Distinction and Honors in Pharmacy, School of Pharmacy, University of Wisconsin-Madison
  • 1994, Academic Excellence Award, Rho Chi Pharmaceutical Honor Society
  • 1993, Sophomore Honors Award, College of Letters and Science, University of Wisconsin-Madison
  • 1992, Chemistry Enrichment Award, Department of Chemistry, University of Wisconsin-Madison
  • 1991-1995, Wisconsin Academic Excellence Award Scholar, Wisconsin Governor & Wisconsin State Legislature
  • 1991, US Presidential Academic Fitness Award Scholar, President of the United States & the United States of America Congress
  • 1991, Elected Member, Phi Eta Sigma National Honor Society
  • 1991, Elected Member, Phi Kappa Phi National Honor Society
  • 1991, Elected Member, Golden Key International Honor Society

Research Support







Invited Speaker (2005-Present)

National and International Invited Speaker Presentations

1.Yale University, Department of Biomedical Engineering, New Haven, CT. 2005.

2.Harvard University, Division of Engineering and Applied Sciences, Cambridge, MA. 2005.

3.UNC-Chapel Hill, Chapel Hill, NC. 2005.

4.10th Annual Liposome Research Days & 1st UNC Drug Conference, Chapel Hill, NC. 2006.

5.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Phoenix, AZ. Symposium on Phospholipids:"Lipids in Nanotechnology II". Invited Speaker. Presentation Title: “Designed Phospholipid Self-Assemblies in Drug Delivery and Nanomedicine”. 2010. [44]

6.American Oil Chemist's Society (AOCS) Annual Meeting & Exhibition, Cincinnati, OH. Symposium on “Phospholipids in Pharma and Cosmetics Applications”. Invited Speaker. Presentation Title: "Phospholipid Nanopharmaceuticals in Advanced Drug Delivery". 2011. [45]

7.International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on “Solid-State Transformation During Formulations and Processing”. Invited Speaker. Presentation Title: "Water Vapor-Solid Interactions and Effects on Solid-State Phase Transitions in Engineered Microparticulate/Nanoparticulate Pharmaceutical Powders". 2011.

8. International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-13). Indianapolis, IN. Symposium on “Imaging of Drugs and Dosage Forms to Better Understand Dissolution”. Invited Speaker. Presentation Title: "Imaging Techniques for Designed Microparticulate/Nanoparticulate Pharmaceutical Powders". 2011.

9. American Chemical Society (ACS) 242nd Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry-Symposium on “Nanomedicine: Colloids & Surface Science”. Denver, CO.

Symposium Session Chair Presider [46]

Invited Symposium SpeakerPresentation Title: "Rational Design, Development, and Optimization of Nanopharmaceuticals for Targeted Drug Delivery in Nanomedicine: An Interfacial and Colloidal Science Approach”. 2011.[47]

10. 4th Annual AAPS Nanotechnology & Nanomedicine Symposium, Louisville, KY. Invited Speaker. Presentation Title: "Advanced Spray-Dried Vancomycin Hydrochloride and Clarithromycin Lipospheres for Targeted Pulmonary Inhalation Aerosol Delivery." 2011.

11. Pfizer, Inc., Worldwide Research & Development, Global Headquarters, Groton, CT. Invited Speaker. Presentation Title: "Engineering Particles by Advanced Spray Drying for Drug Delivery." 2011.

12. Center for Pulmonary Research, Children's Hospital Research Institute, The Ohio State University, Columbus, OH. Invited Speaker in the Translational Pulmonary Research Seminar Series. Presentation Title: "Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012.

13. International Conference & Exhibition on Nanotechnology & Nanomedicine. Omaha, NE. Invited Speaker. Presentation Title: "Advances in Targeted Lung Nanomedicine as Inhalable Multifunctional Microparticles & Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012.

14.Transcept Pharmaceuticals. Invited Webinar Speaker. Presentation Title: "Fundamental and Applied Aspects of Sustained Release Injectible Depot Delivery". 2012.

15. Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Invited Speaker. Presentation Title: "Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery." 2012. [48]

16. Lovelace Respiratory Research Institute (LRRI). Albuquerque, NM. Invited Speaker in the LRRI and CNTC Seminar Series. Presentation Title:"Advances in Targeted Lung Nanomedicine as Aerosolized Multifunctional Microparticles and Nanoparticles for Pulmonary Disease Treatment and Prevention." 2012. [49]

17. Controlled Release Society (CRS) 39th Annual Meeting & Exhibition. Quebec City, Quebec, Canada. Invited Speaker. CRS Workshop: "Mucosal Drug and Gene Delivery: Barriers and Opportunities." Presentation Title: "Pulmonary Drug Delivery". 2012.[50]

18. 1st International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis. University of Delaware, College of Health Sciences, Newark, DE. Organizing Committee Member [51]. Nano Drug Delivery Session Chair Presider [52]. Invited Symposium Speaker in the Nanomedicine Session. Presentation Title: "Advances in Targeted Lung Nanomedicine as Multifunctional Microparticles & Nanoparticles for Targeted Pulmonary Delivery." 2012. [53]

19. Wayne State University Applebaum College of Pharmacy, Department of Pharmaceutical Sciences Seminar Series. Detroit, MI. Invited Speaker. 2012.[54]

20. North American Cystic Fibrosis Conference (NACFC), Orlando, FL. Invited Symposium Speaker. NACFC Aerosol Symposium: "Aerosol Treatments in CF: Clearing the Fog." Presentation Title: "Aerosol Formulation Issues." 2012.[55]

21. 19th World Congress of the International Society of Aerosols in Medicine (ISAM), Chapel Hill, NC. Invited Speaker. ISAM Workshop: "Nanomedicine & Nanotoxicology: Inhaling nanoparticles by accident and on purpose-challenges and opportunities for toxicology and therapeutics." Presentation Title: "Nanotechnology in Dry Powder Inhalation Aerosol Formulations." 2013.[56]

22. AAPS/USP/FDA/IPAC Workshop on Inhaled Drug Products, United States Pharmacopeia (USP), Rockville, MD. Invited Speaker. "Inhaled Drug Products: Current Practices and the Future of In Vitro Testing Technologies and Regulation." Presentation Title: "Solid-State Characterization and Nanotechnology in Inhalation Aerosol Formulation Development." 2013. [57]

23. Association of Inhalation Toxicologists (AIT) Annual Conference, Hannover, Germany. Invited Speaker. Session: "Nanomaterials." Presentation Title: "Nanomaterials as an Aerosol Formulation Carrier in Inhalation Aerosol Nanomedicine." 2013. [58]

24. Eastern Analytical Symposium & Exhibition (EAS), Somerset, NJ. Invited Speaker. Coblentz EAS Session: "Spectroscopic Applications in Biologics." Presentation Title:"Characterization and Spectroscopic Applications in Pulmonary Delivery and Advanced Dry Powder Inhalers." 2013. [59] [60]

25.Buchi Hands-On Spray Drying Course, Newark, DE. Invited Speaker Presentation: "Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying." 2014. [61]

26.American Chemical Society (ACS) 249th Annual Meeting & Exhibition, Division of Colloid & Surface Chemistry Symposium, Denver, CO. Invited Symposium Presentation: "Advances in Targeted Multifunctional Inhalation Aerosols with Nanotechnology and Solid-State Particle Engineering Design." 2015.

27. American Thoracic Society (ATS) International Conference joint with ISAM, Denver, CO. ATS/ISAM Presentation: "Multifunctional Nanotechnology in Lung Surfactant-Mimic Inhalation Aerosols as High-Performing Dry Powder Inhalers for Targeted Pulmonary Medicine." 2015.

28. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: "Inhalation Pharmaceuticals: Device Design and Formulations." 2015. [62]

29. Gordon Research Conference on Lung Biology, Injury, and Repair: Translating Lung Biology to Respiratory Medicine. 2015. Invited Presentation: "Translating Lung Surfactant Biophysics, Nanotechnology, and Nrf2/KEAP-1Genetic Pathway to Advanced Dry Powder Inhalation Aerosol Medicine."

30. Aerogen Webinar "Mechanisms & Pharmacology of Inhaled Drug Delivery" joint with Harvard University School of Public Health (Dr. Joseph Brain), National Jewish/Univ. of Colorado (Dr. Ronina Covar), and Aerogen (Dr. Richard Rose and Dr. Jim Fink). Invited Presentation: "Pharmacology of Inhaled Therapeutics." 2016. [63][64]

31. American Chemical Society (ACS) 90th Colloid & Surface Science Symposium at Harvard Univ. Cambridge, MA. Session: "Nanomaterials for Biomedicine."Invited Symposium Speaker Presentation: "Advances in Biomimetic Nanomaterials for Multifunctional Inhalation Aerosols in Pulmonary Biomedicine."2016.

32. Controlled Release Society (CRS) Annual Meeting, Seattle, WA. Co-Chair, Scientific Symposium: "New Processes, New Materials, and New Products." 2016.

33. International Society of Aerosols in Medicine (ISAM) Aerosol School, Firestone Institute for Respiratory Health & McMaster University, Hamilton,Ontario,Canada.Faculty. 2016.[65]

Invited Webinar Presentations

1. Inhalation Magazine Annual Webinar joint with CSC Publishing and MSP Corporation. Invited Presentation: "Inhalation Pharmaceuticals: Device Design and Formulations." July 14, 2015. 300 attendees. [66]

2. Aerogen Webinar "Mechanisms & Pharmacology of Inhaled Drug Delivery" joint with Harvard University School of Public Health (Dr. Joseph Brain), National Jewish/Univ. of Colorado (Dr. Ronina Covar), and Aerogen (Dr. Richard Rose and Dr. Jim Fink). Invited Presentation: "Pharmacology of Inhaled Therapeutics." January 19, 2016. 960 attendees.[67][68]

International/National Spotlight Research Media Coverage

International

1.Insight & Interview: Drug Delivery & Formulation-Controlled Release. World Pharmaceutical Frontiers (2011) 2 (September): 61-64.[69]

2.Insight & Interview: Meeting Manufacturing Challenges Tied to Extended-Release Injectables. Pharmaceutical Technology (2012) 36 (5): 40-47.[70]

3.Named in “Top Reviewers in 2012. Nanomedicine: Nanotechnology, Biology, and Medicine (2012) [Impact Factor: 6.155] [71]

4.Named in “Top Reviewers in 2013. Nanomedicine: Nanotechnology, Biology, and Medicine (2013) [Impact Factor: 6.155] [72]

5.High-Precision Pulmonary Medicine. International Innovation (2015) 185 (Health & Nanomedicine):99-101. [73][74]

6.Aerosol Medicine. Pan European Networks: Science & Technology (2015) 16:1-2. [75]

7.Pulmonary Disease Research. Adjacent Government (2015): 80-81.[76]

8.Acknowledgement to Reviewers of Pharmaceutics in 2014. Pharmaceutics (2015) 7: 1-2.

9.Named in “Top Reviewers in 2014”. Nanomedicine: Nanotechnology, Biology, and Medicine (2015) [Impact Factor: 6.155][77]


National

1.In the Spotlight: May 21, 2014College News: UA College of Pharmacy (2014)[78]

2.Nov. 19, 2014Bulletin: UA College of Pharmacy(2014)[79]

3.Grants: Nov. 19, 2014 College News: UA College of Pharmacy (2014)[80]

4. Grants: Jan. 26, 2015 | College of Pharmacy - University of Arizona UA College of Pharmacy[81]

5.March 2015 - AHSC New Awards (2015) [82]

6. In the Pharmacy Spotlight AHSC (2015)[83]

7. College of Pharmacy Faculty Earn Leadership Roles, Professional Honors UA@Work (2015)[84]

8. Three Earn Recognition at College of Pharmacy UA College of Medicine: AHSC News Includes Many Activities for Fall DOM Calendars(2015)[85]

9.College of Pharmacy faculty earn leadership roles, professional honorsCOP in the News: Oct. 27, 2015(2015)[86]

10.In the Pharmacy Spotlight COP in the News: Sept. 21, 2015 (2015) [87]

11.In the Pharmacy SpotlightAHSC Announcements - Sep 18, 2015(2015)[88]

12.In the Spotlight: Aug. 31, 2015 College News: UA College of Pharmacy(2015)[89]

13. "KEYS Research Internship" (2015)[90]

14. "UROC Research Consortium" UROC Prep (2015) [91]

15."Winter Series Lung Conference: Lung Research" UA College of Medicine & Arizona Respiratory Center (2015)[92]

16. Univ of Arizona College of Pharmacy Homepage Rotating Research Group Profile (2015) [93]

17. COP faculty member develops treatments for lung diseases (2015)[94]

18.UA College of Medicine, Dept of Medicine, faculty research news plus video [95]

19.UA Health Sciences Office of Public Affairs faculty research news plus video [96]

Short-Course/Workshop Instructor

1.Aerosol School 2-Day Workshop Creator & Instructor: "Aerosol Science Fundamentals and Inhalation Aerosol Delivery", NIH-NCI Cancer Nanotechnology Training Center (CNTC), April 17-18 2012.

2.Buchi Hands-On Spray Drying Course, Buchi U.S. Headquarters. New Castle, DE. Course Instructor. Invited Presentation Title: "Engineering Particles by Advanced Organic Solution Spray Drying for Nanopharmaceuticals and Targeted Pulmonary Inhalation Aerosol Delivery." 2012. [97]

3.Buchi Hands-On Spray Drying Course, Newark, DE. Course Instructor. Invited Presentation Title: "Designing High Performing Microparticulate/Nanoparticulate Dry Powder Inhalers by Organic Solution Advanced Spray Drying." 2014. [98]

4.ISAM Aerosol School, Firestone Institute for Respiratory Health & McMaster University, Hamilton, Ontario, Canada. Faculty. 2016. [99]

Journal Publications

== 2001-2009 ==

1. Mansour H., Wang D.-S., Chen C.-S., and Zografi G. Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol. Langmuir (2001) 17 (21) October 16: 6622-6632. (Impact Factor: 4.457)[100]

2. Mansour, H.M. and Zografi G. The Relationship Between Water Vapor Absorption and Desorption by Phospholipids and Bilayer Phase Transitions. Journal of Pharmaceutical Sciences (2007) 96 (2) February: 377-396. (Impact Factor: 2.590)[101]

3. Mansour, H.M. and Zografi G. Relationships Between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers and Monolayers at the Air-Water Interface. Langmuir (2007) 23 (7) March 27: 3809-3819. (Impact Factor: 4.457)[102]

4. Hickey, A.J., Mansour, H.M., et al. Physical Characterization of Component Particles Included in Dry Powder Inhalers: I. Strategy Review and Static Characteristics. Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue (2007) 96 (5) May: 1282-1301. (Impact Factor: 2.590)[103]

5. Hickey, A.J., Mansour, H.M., et al. Physical Characterization of Component Particles Included in Dry Powder Inhalers: II. Dynamic Characteristics. Journal of Pharmaceutical Sciences: Special Issue David Grant Dedicated Issue (2007) 96 (5) May: 1302-1319. (Impact Factor: 2.590)[104]

6. Mansour, H.M. and Hickey, A.J. Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review. AAPS PharmSciTech (2007) 8 (4) November 30: Article 99:E1-E16. (Impact Factor: 1.641)[105]

7. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes. Respiratory Drug Delivery (2008) 3: 897-900. [106]

8. Mansour H.M., Damodaran S., and Zografi G. Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air-Water Interface: Implications for Pulmonary Surfactant Delivery. Molecular Pharmaceutics (2008) 5 (5) October 6: 681-695. (Impact Factor: 4.384)[107]

9. Mansour, H.M., Rhee, Y.S., and Wu, X. Nanomedicine in Pulmonary Delivery. International Journal of Nanomedicine (2009) 4 December: 299-319.(Impact Factor: 4.383)[108]


== 2010 ==

10. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate. Journal of Pharmaceutical Sciences (2010) 99 (8) March 2: 3398-3414.(Impact Factor: 2.590)[109]

11. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Drug Blends with Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate. Journal of Pharmaceutical Sciences (2010) 99 (8) March 10: 3415-3429. (Impact Factor: 2.590)[110]

12. Mansour, H.M., Xu, Z., and Hickey, A.J. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers. Journal of Pharmaceutical Sciences (2010) 99 (8) March12; 3430-3441.(Impact Factor: 2.590)[111]

13. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J., and Hickey, A.J. Heterogenous Particle Deaggregation and Its Implications for Therapeutic Aerosol Performance. Journal of Pharmaceutical Sciences (2010) 99 (8) March 15: 3442-3461.(Impact Factor: 2.590)[112]

14. Mansour, H.M., Sohn, M., Al-Ghananeem, A., and DeLuca P.P. Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects. Invited Paper. International Journal of Molecular Sciences: Special Issue-Material Sciences and Nanotechnology Section - Biodegradability of Materials in Biomedical Applications. (2010) 11: 3298-3322. (Impact Factor: 2.862)[113]

15. Rhee, Y.S., Park, C.W., DeLuca, P.P., and Mansour, H.M. Sustained-Release Injectable Drug Delivery Systems. An Invited Paper. Pharmaceutical Technology: Special Issue-Drug Delivery (2010) November: 6-13. [114]

16. Hayes, D. Jr., Zwischenberger, J.B., and Mansour, H.M. Aerosolized Tacrolimus: A Case Report in a Lung Transplant Recipient. Transplantation Proceedings (2010) 42 (9) November: 3876-3879.(Impact Factor: 1.061) [115]

17. Wu, X., Li, X., and Mansour, H.M. Surface Analytical Techniques in Solid-State Particle Characterization: Implications for Predicting Performance in Dry Powder Inhalers. Invited Paper. KONA Powder and Particle Journal (2010) 28: 3-19/ (Impact Factor: 1.227) full text[116] [117]


== 2011 ==

18. Xu, Z., Mansour, H.M., and Hickey, A.J. Particle Interactions in Dry Powder Inhaler Unit Processes. Journal of Adhesion Science and Technology: Special Issue on Adhesion Aspects in Pharmaceutical Sciences (2011): 25 (4/5) 451-482. (Impact Factor: 1.175)[118]

19. Rhee, Y.S. and Mansour, H.M. Nanopharmaceuticals I: Nanocarrier Systems in Drug Delivery. International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals. (2011) 8 (1/2): 84-114.(Impact Factor: 1.144)[119]

20. Wu, X. and Mansour, H.M. Nanopharmaceuticals II: Application of Nanoparticles and Nanocarrier Systems in Pharmaceutics and Nanomedicine. International Journal of Nanotechnology: Special Issue-Nanopharmaceuticals. (2011) 8 (1/2): 115-145. (Impact Factor: 1.144)[120]

21. Wu, X.,and Mansour, H.M. Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Invited Paper. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: Special Issue-Optimizing a Therapeutic with Anti-Inflammatory Agents: Novel Drug Delivery Systems. (2011)10 (3): 215-229. [121]

22. Park, C.W., Hayes, D. Jr., and Mansour, H.M. Pulmonary Inhalation Aerosols for Targeted Antibiotics Drug Delivery. European Pharmaceutical Review. (2011) 16 (1): 32-36.[122]

23. Mansour, H.M. Molecular Forces and Self Assembly in Colloid, Nano Sciences and Biology. Invited Paper. Journal of the American Chemical Society. (2011) 133 (13): 5162. (Impact Factor: 9.907) [123]

24. Hayes, D. Jr and Mansour, H.M. Improved Outcomes of Patients with End-Stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure. Lung. (2011) 189 (5): 409-415. (Impact Factor: 2.271)[124] [125]

25. Hayes, D. Jr., Ball, A.M., Mansour, H.M., Martin, C.A.,and Flynn, J.D. Fungal Infection in Heart-Lung Transplant Recipients Receiving Single-agent Prophylaxis With Itraconazole. Experimental and Clinical Transplantation (2011)9 (6): 399-404. [126].

26. Rhee, Y.S., Sohn, M., Woo, B.H., Thanoo, B.C., DeLuca, P.P., and Mansour, H.M. Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres. AAPS PharmSciTech: Special Theme Issue-Sterile Products: Advances and Challenges in Formulation, Manufacturing, Devices and Regulatory Aspects.(2011)12 (4):1293-1301. (Impact Factor: 1.641)[127] [128]

27. Li, X. and Mansour, H.M. Physicochemical Characterization and Water Vapor Absorption of Organic Solution Advanced Spray Dried Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery. AAPS PharmSciTech: Special Theme Issue: Advances in Pharmaceutical Excipients Research and Use: Novel Materials, Functionalities and Testing (2011)12(4):1420-1430. (Impact Factor: 1.641)[129] [130]


== 2012 ==

28. Hayes, D. Jr., Winkler, M.A., Kirkby, S., Capasso, P., Mansour, H.M. and Attili, A.K. Preprocedural Planning with Prospectively Triggered Multi-Detector Row CT Angiography prior to Bronchial Artery Embolization in Cystic Fibrosis Patients with Massive Hemoptysis. Lung (2012)190 (2)April:221-225.(Impact Factor: 2.271)[131]

29. Hayes, D. Jr. and Mansour, H.M. Vanishing Bronchus Intermedius Syndrome in a Pediatric Patient with Cystic Fibrosis After Lung Transplantation. Pediatric Transplantation: The Official Journal of the International Pediatric Transplant Association (2012)16(8):333-337. [Impact Factor: 1.441][132]

30. Hayes, D. Jr., Mansour, H.M., Kirkby, S., and Phillips, A.B. Rapid Acute Onset of Bronchiolitis Obliterans Syndrome in a Lung Transplant Recipient After Respiratory Syncytial Virus Infection." Transplant Infectious Diseases (2012)14 (5): 548-550. [Impact Factor: 2.064][133]

31. Duan, J.H., Mansour, H.M., Zhang, Y.D., Deng, X.M., Zhao, J.F. Reversion of Multi-Drug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/poly(butylcyanoacrylate) Nanoparticles. International Journal of Pharmaceutics (2012) 426 (1-2): 193-201. (Impact Factor: 3.650)[134]

32. Park, C.W., Mansour, H.M., Oh, T.O., Kim, J.Y., Ha, J.M., Lee, B.J., Chi, S.C., Rhee, Y.S., Park, E,S. "Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications." International Journal of Pharmaceutics (2012) 436 (1-2):652-658.(Impact Factor: 3.650) [135]

33. Park, C.W., Rhee, Y.S., Vogt, F.G., Hayes, D Jr., Zwischenberger, J.B., DeLuca, P.P., and Mansour, H.M. Advances in Microscopy and Complementary Imaging Techniques to Assess the Fate of Drugs Ex-Vivo in Respiratory Drug Delivery. Invited Paper. Advanced Drug Delivery Reviews: Special Theme Issue-Computational and Visualization Approaches in Respiratory Delivery. (2012) 64 (4) March 30: 344-356. (Impact Factor: 15.038)[136]

34. Willis, M.L., Hayes, D Jr., and Mansour, H.M. Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Lung (2012) 190 (3): 251-262.(Impact Factor: 2.271)[137] [138]

35.Mansour, H.M. "Aerosol Formulation Issues." Pediatric Pulmonology (2012) 47 (35):149-151. (Impact Factor: 2.297) [139]


== 2013 ==

36. Meenach, S.A. Vogt,F.G., Anderson, K.W., Hilt, J.Z., McGarry,R.C., and Mansour, H.M.. Design, Physicochemical Characterization, and Optimization of Organic Solution Advanced Spray-Dried Inhalable Dipalmitoylphosphatidylcholine (DPPC) and Dipalmitoylphosphatidylethanolamine Poly(Ethylene Glycol) (DPPE-PEG) Microparticles and Nanoparticles for Targeted Respiratory Nanomedicine Delivery as Dry Powder Inhalation Aerosols. International Journal of Nanomedicine (2013) 8:275-293.(Impact Factor: 4.383)[140]

37. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and Mansour, H.M. Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer. European Journal of Pharmaceutical Sciences (2013) 49 (4): 699-711.(Impact Factor: 3.350)[141]

38. Wu,X., Hayes, D Jr., Zwischenberger, J.B., Kuhn, R.J., and Mansour, H.M. Design and Physicochemical Characterization of Advanced Spray-Dried Tacrolimus Multifunctional Particles for Inhalation. Drug Design, Development, and Therapy (2013) 7:59-72. (Impact Factor: 3.028) [142]

39. Wu,X., Zhang, W., Hayes, D Jr., and Mansour, H.M. Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray-Dried Cyclosporine A Multifunctional Particles for Dry Powder Inhalation Aerosol Delivery. International Journal of Nanomedicine (2013) 8 :1269-1283.(Impact Factor: 4.383)[143]

40. Park, C.W., Li X., Vogt, F.G., Hayes, D. Jr., Zwischenberger, J.B., Park, E.S. and Mansour, H.M. Advanced Spray Dried Design, Physicochemical Characterization and Aerosol Dispersion Performance of Vancomycin and Clarithromycin Multifunctional Controlled Release Particles for Targeted Respiratory Delivery as Dry Powder Inhalation Aerosols.. International Journal of Pharmaceutics (2013) 455 (1–2): 374–392.(Impact Factor: 3.785)[144]

41. Zheng Z, Zhang W, Sun W, Li X, Duan J, Cui J, Feng Z, and Mansour, H.M. Influence of the Carboxymethyl Chitosan Anti-Adhesion Solution on the TGF-β1 in a Postoperative Peritoneal Adhesion Rat. Journal of Materials Science: Materials in Medicine (2013) 24 (11): 2549-2559. (Impact Factor: 2.587) [145]

42. Duan J.H., Vogt, F.G., Li X., Hayes, D. Jr., and Mansour, H.M. Design, Physicochemical Characterization and Aerosolization of Organic Solution Advanced Spray Dried and Co-Spray Dried Moxifloxacin and Ofloxacin Dipalmitoylphosphatidylcholine (DPPC) Microparticulate/Nanoparticulate Powders for Pulmonary Inhalation Aerosol Delivery. International Journal of Nanomedicine (2013) 8: 3489-3505. [146](Impact Factor: 4.383)

43. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., Mansour, H.M., and McConnell, P.I. Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction. Journal of Artificial Organs (2013) 16 (3): 382-385. (Impact Factor: 1.441)[147]

44. Hayes, D. Jr., Baker, P.B., Mansour, H.M., Peeples, M.E., and Nicol, K.K. Interstitial Lung Disease in a Child with Antisynthetase Syndrome. Lung (2013) 191 (4): 441-443. (Impact Factor: 2.271)[148]

45.Hayes, D. Jr., Daniels, C.J., Mansour, H.M., Kopp, B.T., Yates, A.R., McCoy, K.S., Patel, A.V., and Kirby, S. Right Heart Catherization Measuring Central Hemodynamics in Cystic Fibrosis During Exercise. Respiratory Medicine (2013): 107 (9): 1365–1369. [Impact Factor: 3.086][149]

46. Hayes, D. Jr., Daniels, C.J., Mansour, H.M., Kopp, B.T., Yates, A.R., Preston, T., and Kirby, S. Identification of the Nodose Ganglia and TRPV1 in Swine. Lung (2013): 191(5):445-447(Impact Factor: 2.271)[150]

47.Hayes, D Jr., Kirkby, S., McCoy, K.S., Mansour, H.M., Khosravi, M., Strawbridge, H., and Tobias, J.D. Reduction of Lipid-Laden Macrophage Index After Laproscopic Nissen Fundoplication in Cystic Fibrosis Patients After Lung Transplantation. Clinical Transplantation (2013) 27 (1): 121-125.(Impact Factor: 1.522) [151]


== 2014 ==

48. Hayes, D. Jr., Yates, A.R., Duffy, V., Tobias, J., Mansour, H.M., Olshove, V., and Preston, T.J. Rapid placement of bicaval dual-lumen catheter in a swine model of venovenous ECMO. Journal of Investigative Surgery (2014): 27(1):27-31. [Impact Factor: 1.158] [152]

49. Hayes, D. Jr., Adler, B., Turner, T.L., and Mansour, H.M.. Alternative Tacrolimus and Sirolimus Regimen Associated with Rapid Resolution of Posterior Reversible Encephalopathy Syndrome After Lung Transplantation. Pediatric Neurology (2014) 50: 272-275.(Impact Factor: 1.695)[153]

50. Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Physicochemical Characterization and Aerosol Dispersion Performance of Organic Solution Advanced Spray Dried Microparticulate/Nanoparticulate Antibiotic Dry Powders of Tobramycin and Azithromycin for Pulmonary Inhalation Aerosol Delivery. European Journal of Pharmaceutical Sciences (2014) 15: 191-205. (Impact Factor: 3.350) [154]

51.Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers. Journal of Aerosol Medicine & Pulmonary Drug Delivery (2014): 27 (2):81-93. (Impact Factor: 2.798)[155]

52. Li X., Vogt, F.G., Hayes, D. Jr., and Mansour, H.M. Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Co-Spray Dried Antibiotics with Mannitol as Respirable Microparticles/Nanoparticles for Targeted Pulmonary Delivery as Dry Powder Inhalers. Journal of Pharmaceutical Sciences (2014)103(9): 2937-2949. [Impact Factor: 2.590][156]

53. Muralidharan, P., Mallory, E., Malapit, M., Hayes, D. Jr., and Mansour, H.M. Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Pharmaceutics: Special Issue: Liposomal Technologies (Guest Editor: Prof. Timothy D. Heath, UW-Madison) (2014) 6 (2): 333-353. [157] [158]

54. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and Mansour, H.M. High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies. AAPS PharmSciTech (2014)15(6) December:1574-1587. [Impact Factor: 1.641] [159] [160]

55. Hayes, D. Jr., Tobias, J.D., Mansour, H.M., Kirkby, S., McCoy, K.S., Daniels, C.J., and Whitson, B.A. Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease. American Journal of Respiratory and Critical Care Medicine (2014) 190 (8):898-905. [Impact Factor: 12.996] [161]
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [162]


== 2015 ==

56. Stocke, N., Meenach, S.A.,Arnold, S.M., Mansour, H.M.*,and Hilt, J.Z. Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery via Spray Drying. International Journal of Pharmaceutics (2015) 479 (2): 320–328. *Corresponding Authors [Impact Factor: 3.650] [163]

57. Hayes, D. Jr., McCoy, K.S., Whitson, B.A., Mansour, H.M. , and Tobias, J.D. High-Risk Age Window for Mortality in Children with Cystic Fibrosis after Lung Transplantation. Pediatric Transplantation (2015)19(2):206-210.(Impact Factor: 1.441)[164]

58. Hayes, D. Jr., Black, S.M., Tobias, J.D., Mansour, H.M., and Whitson, B.A. Influence of pulmonary hypertension on survival in advanced lung disease. Lung (2015)193(2):213-21. [Impact Factor: 2.271][165]

59. Muralidharan, P., Hayes, D. Jr., and Mansour, H.M. Dry Powder Inhalers in COPD, Lung Inflammation, and Pulmonary Infections. Expert Opinion on Drug Delivery (2015) 12 (6): 947-962. (Impact Factor: 4.840)[166][167]

60. Muralidharan, P., Malapit, M., Mallory, E., Hayes, D. Jr., and Mansour, H.M. Inhalable Nanoparticulate Powders for Respiratory Delivery. Nanomedicine: Nanotechnology, Biology, and Medicine (2015)11:1189-1199. [Impact Factor: 6.155][168][169]

61.Hayes, D. Jr., Kirkby, S., Whitson, B.A., Black, S.M., Sheikh, S.I., Tobias, J.D., Mansour, H.M., and Kopp, B.T. Mortality Risk and Pulmonary Function in Adults with Cystic Fibrosis at Time of Wait Listing for Lung Transplantation. The Annals of Thoracic Surgery (2015) 100(2): pp. 474-479. [Impact Factor: 3.849][170]

62.Hayes, D. Jr., Whitson, B.A., Ghadiali, S.N., Lloyd, E.A., Tobias, J.D., Mansour, H.M., and Black, S.M. Survival in Adult Lung Transplant Recipients Receiving Pediatric vs. Adult Donor Allografts. The Annals of Thoracic Surgery (2015)100(4):1211-6.[Impact Factor: 3.849][171]

63.Hayes, D. Jr., Patel, A.V., Black, S.M., McCoy, K.S., Kirkby, S.,Tobias, J.D., Mansour, H.M., and Whitson, B.A. Influence of diabetes on survival in cystic fibrosis before and after lung transplantation. The Journal of Thoracic and Cardiovascular Surgery (2015)150(3):707-713. [Impact Factor: 4.168][172]
“F1000Prime Recommended by F1000Respiratory Disorders Faculty” [173]

64. Lu, Q., Harris, V.A., Kumar, S., Mansour, H.M., and Black, S.M. Autophagy in Neonatal Hypoxia Ischemic Brain is Associated with Oxidative Stress. Redox Biology (2015)6:516-523.[174][175]

65. Hayes, D. Jr., Whitson, B.A., Ghadiali, S.N., Tobias, J.D., Mansour, H.M., and Black, S.M. Influence of HLA Mismatching on Survival in Lung Transplantation.Lung (2015)193 (5):789-797.[Impact Factor: 2.271] [176]

66. Hayes, D. Jr., Kopp, B.T.,Tobias, J.D., Woodley, F.W., Mansour, H.M., Tumin D., and Kirkby, S.E. Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation.Lung (2015)193(6):933-8.[Impact Factor: 2.271] [177]


== 2016 ==

67.Hayes, D. Jr., Black, S.M., Tobias, J.D., Kirkby, S., Mansour, H.M., and Whitson, B.A. Influence of Pulmonary Hypertension on Patients with Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation. The Annals of Thoracic Surgery (2016) 101(1):246-52. [Impact Factor: 3.849][178]

68. Hayes, D. Jr., Black, S.M., Tobias, J.D., Mansour, H.M., and Whitson, B.A. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD: Journal Of Chronic Obstructive Pulmonary Disease(2016) 13(1):50-6. [Impact Factor: 2.673] [179]

69. Hayes, D. Jr., Younger, B.R., Mansour H.M., and Strawbridge, H. Precordial Catch Syndrome in Elite Swimmers with Asthma. Pediatric Emergency Care (2016) 32 (2):104-106.

70. Hayes D Jr, Black SM, Tobias JD, Kopp BT, Kirkby SE, Mansour HM, and Whitson BA. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation. The Journal of Heart and Lung Transplantation(2016) (IN PRESS) [Impact Factor: 6.650][180]

71. Hayes, D. Jr., Auletta, J.J., Whitson B.A., Black, S.M., Kirkby, S., Tobias, J.D., and Mansour H.M. Human leukocyte antigen mismatching and survival after lung transplantation in adult and pediatric patients with cystic fibrosis. The Journal of Thoracic and Cardiovascular Surgery (2016)151(2):549-557.[Impact Factor: 4.168] [181]

72. Hayes, D. Jr., Tumin D., Daniels, C.J., McCoy, K.S., Mansour H.M., Tobias, J.D., and Kirkby, S. Pulmonary Artery Pressure and Benefit of Lung Transplantation in Adult Cystic Fibrosis Patients. The Annals Thoracic Surgery(2016): 101(3):1104-1109. [Impact Factor: 3.849]

73. Acosta, M., Muralidharan, P, Meenach, S.A., Hayes, D. Jr., Black, S.M., and Mansour, H.M. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models. Current Pharmaceutical Design(2016)22: (IN PRESS) [Impact Factor: 3.452][182]

74. Muralidharan, P, Hayes, D. Jr., Black, S.M., and Mansour, H.M. Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway. The Royal Society of Chemistry(RSC): Molecular Systems Design & Engineering(2016): 1-18.DOI: 10.1039/C5ME00004A [183]

75. Muralidharan, P, Acosta, M., Hayes, D. Jr., Black, S.M., and Mansour, H.M. Solid State Physicochemical Characterization & Microscopy of Particles in Dry Powder Inhalers. Inhalation (2016): (IN PRESS)

76. Rojo de la Vega, M., Dodson, M., Gross, C., Mansour, H.M., Lantz, R.C., Chapman, E., Wang, T., Black, S.M., Garcia, J.G.N., and Zhang, D. Role of Nrf2 and Autophagy in Acute Lung Injury. Current Pharmacology Reports: Free Radicals Medicine (2016) 2 (2): 91-101. [184][185]

77. Meenach, S.A., Tsoras, A.N., McGarry, R.C., Mansour, H.M., Hilt, J.Z., and Anderson, K.W. Development of Three-Dimensional Lung Multicellular Spheroids in Air- and Liquid-Interface Culture for the Evaluation of Anticancer Therapeutics. International Journal of Oncology (2016)48(4): 1701-1709. [Impact Factor: 3.025][186]

Edited Book (co-Editor)

1. Nanomedicine in Drug Delivery, Kumar, A., Mansour, H.M., Friedman, A., and Blough, E. (Editors), CRC Press/Taylor & Francis, London, United Kingdom. (2013) 469 pages. ISBN: 9781466506169 [187][188][189]

Book Chapters

1. Hickey, A.J. and Mansour, H.M. Book Volume 2, Book Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols. Modified-Release Drug Delivery Technology, Drugs and the Pharmaceutical Sciences Series.728 pages. Rathbone, M. J., Hadgraft, J., Roberts, M.S., Lane, M.E, (Editors), Second Edition, Informa Healthcare, New York, (2008): pp. 573-602. ISBN: 9781420053555 [190]

2. Hickey, A.J. and Mansour, H.M. Book Volume 2, Book Chapter 5: Delivery of Drugs by the Pulmonary Route. Modern Pharmaceutics Volume 2: Applications and Advances, Drugs and the Pharmaceutical Sciences Series,.500 pages. Florence, A.T., Siepmann, J. (Editors), Fifth Edition, Informa Healthcare, New York, (2009): 191-219. ISBN: 9781420065664 [191]

3. Mansour, H.M., Rhee, Y.S., Park, C.W., and DeLuca, P.P. Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine. Lipids in Nanotechnology. 306 pages. Moghis, A. (Editor), American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2012): pp.221-268.ISBN: 9780981893679 [192]

4. Mansour, H.M., Park, C.W., and Hayes, D. Jr. Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine. Nanomedicine in Drug Delivery. 469 pages. Kumar, A., Mansour, H.M., Friedman, A., Blough, E. (Editors), CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. ISBN: 9781466506169 [193] [194][195]

5. Mansour, H.M. and Park, C.W. Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products. The Clinical Nanomedicine Handbook. 365 pages. Brenner, S.A. (Editor), CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.321-338. ISBN: 9781439834787 [196]

6. Mansour, H.M., Xu, Z., Meenach, S.A., Park, C.W., Rhee, Y.S., and DeLuca, P.P. Book Chapter 5: Novel Drug Delivery Systems. Drug Delivery. 550 pages. Mitra, A.K. (Editor), Jones & Bartlett, Burlington, MA. (2015): pp.71-107. ISBN-13: 9781284025682 [197]

7. Mansour, H.M., Muralidharan, P., and Hayes, D. Jr. Book Chapter 8b: Inhaled Nanoparticulate Systems: Composition, Manufacture, and Aerosol Delivery. The ISAM Textbook of Aerosol Medicine. Dhand, R. (Editor-in-Chief), Rothen-Rutishauser, B., and Hickey A.J. (Associate Editors), International Society of Aerosols in Medicine (ISAM)/Mary Ann Libert Publishing, Inc. Rochelle, NY. (2015): 353-394. [198]

8. Mansour, H.M., Park, C.W., and Bawa, R. Book Chapter 9: Design and Development of Approved Nanopharmaceutical Products. Handbook of Clinical Nanomedicine: From Bench to Bedside. 3000 pages. Bawa,R., Audette, G., and Rubinstein, I. (Editors), Pan Stanford Publishing/CRC Press/Taylor & Francis, Inc., Boca Raton, FL. (2016): 233-272. ISBN: 9789814316170 [199]

9. Mansour, H.M., Myrdal, P.B., Younis, U., Muralidharan, P., Hillery, A. M., and Hayes, D. Jr. Book Chapter 11: Pulmonary Drug Delivery. Drug Delivery: Fundamentals and Applications. 630 pages. Hillery, A.M. and Park, K. (Editors), Second Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2016): 249-277. ISBN 9781482217711[200]

Professional Memberships

1.Academy of Pharmaceutical Sciences of Great Britain (APSGB)

2.American Thoracic Society (ATS)

3.American Pharmacists Association (APhA)[201]

4.American Chemical Society (ACS)

5.American Association of Pharmaceutical Scientists (AAPS)

6.American Association of the Colleges of Pharmacy (AACP)

7.American Society for Nanomedicine (ASNM)

8.Controlled Release Society (CRS)

9.European Federation for Pharmaceutical Sciences (EUFPS)

10.International Pharmaceutical Federation (FIP) Board of Pharmaceutical Specialties

11.European Respiratory Society (ERS)

12.International Society for Aerosols in Medicine (ISAM),Co-Chair, Drug Delivery:New Devices & Emerging Therapies Group

13.The Aerosol Society (Great Britain)

14.International Association of Colloid and Interface Scientists (IACIS)

15.The Biochemical Society

16.British Society for Nanomedicine

17.British Thoracic Society

18. The Royal Society of Medicine (Respiratory Medicine)

19. The Royal Society of Chemistry

Honor Societies (Elected Member)

1. Phi Eta Sigma National Honor Society

2. Phi Kappa Phi National Honor Society

3. Golden Key International Honor Society

4. Rho Chi Pharmaceutical Honor Society

5. Sigma Xi Scientific Research Honor Society

Retrieved from "https://openwetware.org/mediawiki/index.php?title=Dr.HeidiM.Mansour&oldid=943498"